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The Escherichia coli protein, BirA, functions as an allosteric transcriptional 
repressor and a metabolic enzyme. BirA catalyzes synthesis of its intermediate, bio-5’-
AMP, from biotin and ATP. In its repressor function, binding of bio-5’-AMP promotes 
homodimerization that is a prerequisite to DNA binding at the biotin biosynthetic operon.  
As an enzyme, BirA forms a heterodimer with the biotin carboxyl carrier protein and 
transfers biotin to activate the first committed step of fatty acid synthesis. Based on 
structural data the unliganded repressor is characterized by four flexible loops that are 
ordered in the ligand-bound homodimers. Two of these loops participate in intermediate 
binding. The biotin binding loop (BBL) orders over biotin and participates directly at the 
dimer interface. The adenylate binding loop (ABL), located distal to the interface orders 
over the adenine ring. Single site mutations in a hydrophobic cluster of the ABL are 
investigated for small ligand binding and dimerization employing isothermal titration 
calorimetry and sedimentation equilibrium techniques. Results indicate that coupling 
between adenylate binding and dimerization is compromised in each mutant. Further, the 
ligand-induced disorder-to-order transition in the ABL is shown to be integral to the 
allosteric response. The ABL and BBL are also examined for their role in the structural 
mechanism of intermediate-induced protein:DNA interaction. Based on a structural 
model of the repressor:DNA complex, electrostatic interactions are predicted between the 
flexible loops and the DNA backbone. The DNA binding properties of mutants in the 
loops are assessed by the DNase I footprinting technique. Contrary to predictions, results 
indicate no direct participatation of the loops in the protein:DNA interaction. Finally, the 
same loops are inspected for their role in mutually exclusive, isoenergetic protein:protein 
interactions. Combined with mutant proteins previously examined in homodimerization, 
additional mutants in the flexible loops are investigated in alternate protein:protein 
interactions. The hetero- and homo-dimerization processes are monitored by inhibition 
DNase I footprinting titrations, a kinetic assay, and sedimentation equilibrium 
measurements. Results indicate an overlap in structural determinants important for both 
interactions. Further, “hotspots” have evolved that are exclusive to one but not the other 
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I. General Introduction 
Decades ago François Jacob wrote, “…evolution does not produce innovations 
from scratch. It works with what already exists, either transforming a system to give it 
a new function, or combining several systems to produce a more complex one (1).” 
The remarkable ability of proteins to develop multifunctional properties and to 
integrate them through the conservation of sequence and/or structure is of 
considerable evolutionary significance. The E. coli Biotin Regulatory System is an 
excellent model to investigate this phenomenon. The work presented in this thesis is 
focused on elucidating the structural basis of multi-functionality in this system.  
  
The central component of the E. coli Biotin Regulatory System, BirA, is a 
bifunctional protein. It funnels biotin into metabolism or regulates biotin biosynthesis 
by switching between two alternate interactions (2, 3). BirA binds substrates biotin 
and ATP to catalyze synthesis of its intermediate, bio-5’-AMP(4). Binding of this 
small molecule allosterically activates the transcription repression function of BirA 
through driving formation of a homodimer that binds the biotin operon (5-7). BirA 
also forms a heterodimer with a biotin acceptor protein, apoBCCP, a subunit of the 
acetyl-CoA carboxylase enzyme (ACC). This results in biotin transfer to ACC, 
thereby activating the enzyme that catalyzes the first committed step of fatty acid 
synthesis. Alternative protein:protein interactions regulate the functional switch in 
BirA.   
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The BirA system serves as a model for investigating structural features 
important to protein:ligand, protein:protein and protein:DNA interactions in the 
context of its multi-functionality. The focus of this thesis is three-fold: (1) to elucidate 
the role of a flexible loop important in intermediate binding to the allosteric response 
in BirA, (2) to investigate the role of flexible loops involved in intermediate binding 
and homodimerization in the structural mechanism of effector-induced protein:DNA 
interaction, and (3) to investigate the role of the same flexible loops to the functional 
switch between transcriptional regulation and metabolism. The topics covered in this 
general introduction are intended to provide the reader with background on the E. coli 
Biotin Regulatory System and to place this work in a broader context.  
 
A. Allosteric Regulation 
Regulation of protein function through allostery is a concept that emerged 
from early research on feedback inhibition of enzymes(8, 9). In the original allosteric 
model a protein contains a regulatory site distinct from the catalytic site that is 
responsible for regulating protein function. The catalytic activity of a protein can be 
activated or attenuated by binding of an activator or inhibitor at the distant regulatory 
site. The mechanism of regulation can be explained by a conformational change in the 
protein that accompanies binding thereby altering the catalytic activity of the protein 
(10, 11). Monod called this regulatory site an “allosteric” binding site (12, 13). Many 
allosteric systems can be explained by two models: the concerted MWC model by 
Monod, Wyman and Changeux, and the sequential model by Koshland, Nemethy and 
Filmer. These models provide mechanical views of allostery. In general they 
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postulate two conformations of an enzyme, the tense (T) and relaxed (R) states, that 
exhibit differential affinities for a substrate. Binding of a small molecule to the 
allosteric site shifts the equilibrium between the two states. In a broader and more 
current view of allostery, macromolecules exist as ensembles that are shifted in 
response to small ligand binding or post-translational modification, thereby affecting 
functional properties. The resulting allosteric response is in essence a change in the 
thermodynamic properties of the system and is realized through a conformational 
and/or dynamic change in the macromolecule.  
 
Understanding allosteric regulation requires elucidation of the mechanisms by 
which a signal associated with effector binding is propagated through the 
macromolecule to affect its functional features. In some systems the allosteric signal 
is transmitted via a conserved network of interactions from the ligand binding site to a 
distant regulatory site. In others, the signal is transmitted over large distances to effect 
global conformational and/or dynamic changes. One approach to understanding 
allostery is through experimental determination of the significance of structural and 
dynamic changes in a macromolecule for the functional response. 
  
Allostery operates in many cellular processes including metabolism, signal 
transduction, and transcription regulation (14, 15). The E. coli protein, BirA, serves as 
an excellent model for studying allostery. Extensive thermodynamic and structural 
studies have enabled an understanding of the mechanism of allosteric activation in 
BirA. Additionally, data have also provided clues to structural features important to 
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allosteric signal transmission. The following brief introduction to the E. coli Biotin 
Regulatory System provides the necessary background that has lead to the research 
presented in the second chapter of the thesis. 
 
The central component of the E. coli Biotin Regulatory System, BirA, is a 
bifunctional protein that functions as a metabolic enzyme and a repressor of 
transcription initiation (2, 3) (Figure 1). As an enzyme BirA catalyzes the two-step 
biotinylation of the biotin carboxyl carrier protein (apoBCCP), a subunit of the 
acetyl-CoA carboxylase enzyme (ACC). In the first step, apoBirA monomer binds the 
substrates biotin and ATP to catalyze synthesis of the intermediate, bio-5’-AMP. The 
bio-5’-AMP bound form, holoBirA, covalently links the biotin moiety to the ε-amino 
group of a specific lysine residue of BCCP(4). Biotin, when linked to BCCP, is the 
transient carrier of a carboxylate group in its transfer from the donor, bicarbonate, to 
the acceptor, acetyl-CoA, and thus plays the role of an essential cofactor in the first 
committed step of fatty acid biosynthesis. As a transcriptional repressor two BirA 
monomers bind specifically to the 40-base pair biotin operator sequence (bioO) 
blocking access of the RNA polymerase to the two divergent overlapping promoters, 
Pa and Pb, and repressing transcription of the biotin biosynthetic operon (5, 6). 
Formation of the repression complex occurs via two coupled reactions in which 
dimerization is followed by DNA binding (16). ApoBirA is not the active species in 
bioO binding. Rather the bio-5’-AMP-bound repressor binds bioO with high affinity. 
Hence, bio-5’-AMP, serves as an intermediate in biotin transfer to BCCP and as a 






Figure 1. A schematic of the E. coli Biotin Regulatory System 
The activated enzyme, BirA-bio-5’-AMP, switches between functioning as a biotin 





As evidenced by the x-ray crystallographic structure, gel filtration, and 
sedimentation equilibrium studies apoBirA, the unliganded form of BirA is 
monomeric (17, 18). It is a 35.3 kDa protein of 321 amino acids comprising three 
domains (Figure 2). The N-terminal DNA binding domain contains a winged-helix-
turn-helix motif, characteristic of many DNA binding proteins. The central domain 
contains a 7-stranded mixed beta-sheet packed against 5 alpha helices, and five loops 
of which four loops are partially disordered in the crystal structure and are indicated 
in the figure. The central domain contains the ligand binding site and biochemical 
data also indicate its direct role in dimerization and indirect role in DNA binding. The 
C-terminal domain contains a β-sandwich motif and structural data indicate its 
involvement in dimerization.  
 
The mechanism of allosteric activation of BirA has been studied extensively 
using equilibrium thermodynamic and kinetic techniques (19-26). Binding of the 
allosteric activator, bio-5’-AMP, to two apoBirA monomers drives dimerization. 
Results of time-resolved DNase I footprinting and equilibrium thermodynamic 
measurements of repression complex assembly reveal a two-step process of 
dimerization followed by DNA binding (16). Sedimentation equilibrium 
measurements indicate that binding of bio-5’-AMP enhances BirA dimerization by -
4.4 kcal/mol (17, 27). This difference in the dimerization energetics for apoBirA and 
BirA bound to bio-5’-AMP, is equal to the difference in total assembly energetics of 
the repression complex for the two species. Thus allosteric activation is 








Figure 2. A model of the three-dimensional structure of apoBirA obtained from X-ray 
crystallography (18). The four partially disordered loops are indicated in black. The 
model was generated using the program MolMol (28) with the Protein Data Bank file 




the allosteric mechanism in BirA requires determination of the structural and dynamic 
changes in the BirA monomer that accompany activation of dimerization by bio-5’-
AMP. 
 
The magnitude of the allosteric response in BirA can be modulated using 
analogues of the corepressor, bio-5’-AMP (Figure 3). Based on their ligand binding 
properties and abilities to promote repressor dimerization and bioO binding, these 
small ligands are characterized as weak and strong activators (29). Bio-5’-AMP and 
its analog biotinol-AMP (btnOH-AMP) are strong allosteric activators while d-biotin, 
a substrate in bio-5’-AMP synthesis, and the sulfamoyl analog of bio-5’-AMP (btn-
SA) are weak activators of BirA dimerization. While biotin binding results in no 
enhancement of dimerization, btn-SA binding results in a modest enhancement of -1 
kcal/mol. By contrast, btnOH-AMP binding which affords an enhancement of -3.4 
kcal/mol, a value comparable with that for bio-5’-AMP of -4.4 kcal/mol, serves as a 
good mimic of the intermediate. High resolution structures of the repressor bound to 
the weak activator, biotin, and strong activator, btnOH-AMP, have been determined 
by x-ray crystallography and are discussed below (30, 31). Comparison of structures 
and thermodynamic data on apoBirA, and the ligand-bound dimers has provided a 
better understanding of the mechanism of allosteric activation in BirA. Moreover, the 
structural data have offered valuable information on the structural and dynamic 







Figure 3. Chemical structures of the corepressor, bio-5’-AMP, and its analogs. 








The x-ray crystallographic structure of biotin-bound BirA has been 
determined to 2.4 Ǻ resolution. The structure reveals that the repressor is dimeric (30) 
(Figure 4A). The dimerization interface is located at the central domain of each 
monomer and is formed by side by side β-strands to form an extended β sheet. In 
forming the dimer each monomer buries 920 Ǻ2 of solvent accessible surface area. A 
striking feature of this structure is that 3 of the 4 partially disordered loops in 
apoBirA structure appear ordered in the biotin-bound dimer. These loops are 
composed of residues 110-128, 140-146 and 193-199 and participate at the dimer 
interface. Loop 110-128 is referred to as the biotin binding loop as it is ordered over 
the biotin moiety in the crystal structure. Mutations of residues in these loops exhibit 
defective dimerization and DNA binding properties (32, 33). The fourth loop 
comprising residues 212-234, remains disordered in this dimer structure.  
 
The biotin binding loop contains the glycine rich sequence 115GRGRRG120 
which is conserved in all biotin ligases (33). Kinetic and thermodynamic analyses of 
mutants G115S, R118G and R119W of this sequence demonstrated that they are 
involved in biotin and bio-5’-AMP binding, dimerization, and bioO binding (32). 
Based on the biotin-bound dimer structure, these three residues do not interact with 
the biotin moiety. However, other residues within the sequence directly contact the 
ligand. R116 contributes two main-chain hydrogen bonds to biotin and G117 packs 
against the alkyl tail of biotin. While these studies clearly demonstrated the structural 
determinants important for biotin binding, those required for ATP binding remained 
unknown. 
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Biochemical studies have demonstrated a role for the fourth disordered loop 
212-234 in corepressor binding. Early evidence was obtained from proteolytic 
digestion experiments performed with the protease subtilisin that cleaves the BirA 
backbone between residues 217-218 located in the loop (34). The time course of 
subtilisin-catalyzed proteolysis of apoBirA and BirA bound to bio-5’-AMP were 
determined. Binding of the corepressor resulted in a decreased proteolysis rate, 
indicating protection of the fourth loop upon binding bio-5’-AMP. Further, the 
hydroxyl radical footprinting technique was utilized to probe structural and 
conformational changes that take place in the BirA monomer upon ligand binding 
(35). Results indicated a decreased reactivity of the BirA backbone to hydroxyl 
radical agents as a consequence of ligand binding. Bio-5’-AMP binding resulted in 
90-100% protection of segment 215-220 of the fourth loop. Based on these combined 
biochemical results, it was surmised that the fourth loop becomes ordered upon 
binding the corepressor and that its ordering may result in enhanced dimerization.  
 
The ordering of the fourth loop concomitant with corepressor binding was 
confirmed by structural data. Bio-5’-AMP contains a reactive mixed anhydride bond 
and is inherently unstable, which precluded its use in determining the corepressor-
bound structure of BirA. However, the corepressor analog, btnOH-AMP, is a strong 
allosteric activator that mimics bio-5’-AMP in its ability to enhance dimerization of 
BirA and DNA binding. The x-ray crystallographic structure of btnOH-AMP-bound 
BirA has been determined to 2.8 Ǻ resolution and reveals the repressor as a dimer 
(31). As in the biotin-bound dimer structure, the dimer interface is formed via a β-
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strand of the central domain. While the dimer interface of the BirA-biotin and the 
BirA-btnOH-AMP complexes are similar, the energetic difference between the weak 
and strong activator-induced dimerization is -3 kcal/mol. A comparison of the two 
dimer structures reveals some differences. Consistent with greater thermodynamic 
stability, the dimer interface in the btnOH-AMP-bound dimer is larger and extends to 
the C-terminal domain. However, the most significant structural difference is the 
ordering of the fourth flexible loop in the btnOH-AMP-bound dimer. This loop, 
comprising residues 212-234 is located distal to the dimer interface. It is folded over 
the purine ring of the adenylate moiety and is therefore called the adenylate binding 
loop (Figure 4B).  
 
A common approach to understanding allosteric control in macromolecular 
systems involves determination of how conformational and/or dynamic changes that 
occur at the allosteric ligand binding site are transmitted to a distinct site to affect 
function. A brief review of two systems is provided in this section. In the first, small 
ligand binding to an allosteric site alters its local conformation. The allosteric signal 
associated with binding is transmitted through a conserved network of residues to 
affect a distant site. In the second system, small ligand binding similarly alters local 
structural features at the allosteric site. By contrast, in this system the allosteric signal 
is realized via a global conformational change. However, in both examples local 




Figure 4. Models of the three dimensional structures of Ligand-bound BirA dimers 
determined by X-ray crystallography (30, 31). (A) BirA bound by d-biotin. d-biotin is 
shown in black. (B) BirA bound by biotinol-adenylate. Biotinol-adenylate is shown in 
black. The fourth loop is shown in blue. The models were generated using the 




Hsp70s are the 70-kDa heat shock proteins that are essential members of the 
cellular chaperone machinery. These chaperones function in de novo folding of newly 
synthesized polypeptides and the disaggregation and refolding of stress-denatured 
proteins (36, 37). Hsp70 is composed of two binding domains including the C-
terminal substrate-binding domain (SBD) and the N-terminal ATPase domain. Short 
hydrophobic peptide stretches within polypeptide substrates interact transiently with 
the substrate binding domain of Hsp70. The functionality of the SBD is regulated by 
the nucleotide status of the ATPase domain through control of the conformational 
state of the substrate-binding domain. While ATP binding to the ATPase domain 
results in low affinity of Hsp70 proteins for their substrates, the affinity is high when 
ADP or no nucleotide is bound. Additionally, the interdomain allostery in this system 
is bidirectional. That is, substrate binding to the SBD induces a conformational 
change in the ATPase domain to stimulate ATP hydrolysis, thereby resulting in a high 
substrate affinity state.  
 
Several approaches have been taken to understand the allosteric mechanism of 
regulation in Hsp70. Structural data have provided some information on the active 
sites of each domain and interdomain communication. The x-ray crystallographic 
structure of a two-domain construct of the bovine Hsc70 in its nucleotide free-state 
has been determined (38). The structure shows the contact sites between the 
substrate-binding and ATPase domains. The interdomain contacts are formed by one 
side of a helix A of the substrate binding domain which rests in a groove of the 
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ATPase domain with two domains are connected by a linker (Figure 5).  Combined 
structural, biochemical and amide hydrogen-deuterium exchange studies have helped 
elucidate the mechanism of allosteric regulation in Hsp70 (39, 40). Biochemical data 
indicate that a conserved proline located in the ATPase domain and an arginine 
located at the surface of the domain are important to the allosteric mechanism (41). A 
signal transduction pathway has been identified that starts with the conserved proline 
and arginine residues of the ATPase domain surface (42). Mutant proteins assessed 
for ATPase activity and effects on interdomain communication by fluorescence 
techniques enabled identification of key residues that constitute the signaling 
network. These include two positively charged surface exposed residues in the 
ATPase domain and an aspartate residue in the linker connecting the two domains 
(shown in Figure 5). The aspartate is essential for stimulating ATPase activity. ATP 
binding to the ATPase domain causes local changes within the domain that are 
relayed to the SBD. The transmission of the response upon ligand binding occurs via 
this signaling network of residues resulting in a bend in the linker between the 
domains, thereby triggering a low affinity state of the SBD. Local changes in the 
ATPase domain upon ligand binding affect the functional activity of the distant 
substrate binding domain.  
 
2. Thrombin 
 Thrombin is an allosteric serine protease that belongs to the chymotrypsin 
family (43). It is generated in the blood form its precursor prothrombin and plays two 
opposing roles in blood coagulation (44). It acts as a procoagulant in converting 
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substrate, fibrinogen, into an insoluble fibrin clot that anchors platelets to the site of 
lesion to initiate wound repair (45, 46). By contrast, thrombin also acts as an 
anticoagulant by activating protein C (47). Na2+ binding allosterically controls the 
procoagulant function of thrombin, and the anticoagulant function is driven by the 
cofactor thrombomodulin. The review here focuses on the former function of 
thrombin. 
  
Structural, mutagenesis and kinetic investigation allowed identification of three forms 
of the enzyme, E (*), E, and E:Na(+), that interconvert under the influence of ligand 
binding to distinct domains. The transition between the Na(+)-free, E, and the Na(+)-
bound, E:Na(+), is accompanied by conformational changes in the enzyme (48). E (*) 
is most likely an inactive form of thrombin, unable to interact with Na(+)and 
substrate (49). Extensive structural and biochemical investigations on these forms 
have provided an understanding of the mechanism of allosteric regulation in 
thrombin. 
  
There are currently over 50 structures of thrombin bound by Na+ (50). 
Combined with the structural data, alanine scanning mutagenesis of thrombin has 
revealed an allosteric core of residues that cluster around the Na+ site. Mutations in 
this cluster result in energetic defects in Na+ binding (51). Structures of the Na+ free 
and Na+ bound forms have been determined. While they bear many similarities, 





Figure 5.The structure of the Bovine Hsc70 protein (38). 
The ATPase domain (yellow) and substrate binding domains (red) of the two-domain 
construct of the bovine heat shock protein 70. The linker is shown in blue and key 
residues are indicated in black. The model was generated using the program MolMol 






structural determinants within the core are involved in the transition between the Na+ 
free and Na+ bound forms as evidenced from kinetic analyses (53). While Na+ 
binding directly alters the conformation of the core, the resulting allosteric signal is 
propagated through the entire protein to globally alter conformation, thereby affecting 
function. 
 
 Several approaches have been employed to probe the overall conformational 
state of thrombin in response to Na+ binding. Ligands that bind to specific domains 
of thrombin have been utilized to probe more local changes within domains. The use 
of chromogenic substrates has provided valuable information on how the active site 
participates in the allosteric transition (51). Another approach has been to analyze the 
interaction between thrombin and macromolecular ligands that probe a larger surface 
of the enzyme. For example, the potent natural inhibitor, hirudin (54), mimics the 
binding strategy of fibrinogen (55, 56) and serves as an excellent probe of the 
conformational state of the enzyme. These methods have identified structural 
determinants critical to transition of thrombin from one form to the other and have 
offered some idea of the molecular basis of allostery in thrombin. Overall, the 
allosteric response associated with Na+ binding to thrombin is realized through global 
conformational transitions that promote its response to injury. 
 
The second chapter of this thesis is focused on understanding allostery in the 
biotin repressor protein by determining the significance of the structural/dynamic 
changes associated with intermediate binding. The response is realized through 
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ligand-induced dimerization of the protein. In this study, corepressor-induced folding 
of the adenylate binding loop, which is located distal to the dimerization interface, is 
investigated for its role in the allosteric response. 
 
B. Allosteric Regulation of Transcription Factors 
The biotin repressor, BirA, belongs to a large family of allosteric transcription 
factors. The allosteric mechanisms associated with small ligand binding to regulate 
transcription have been extensively studied in many systems. The third chapter of the 
thesis focuses specifically on elucidating the structural mechanism by which small 
ligand binding alters the affinity of the protein:DNA interaction in the E. coli Biotin 
Regulatory System.  
In order to maintain the normal cell viability in response to changes in nutrient 
levels the expression of many genes must be modulated. This regulation is often 
carried out at the level of transcription initiation. A good example to illustrate the 
importance of regulating gene expression is in C. diphtheriae. This organism 
expresses iron binding proteins which sequester iron for biological activities. 
Increased levels of iron uptake can result in formation of reactive hydroxyl radical 
species that can damage biological molecules (57). Alternatively, low levels of iron 
uptake may result in expression of virulence factors. Hence in response to iron levels 
in the cell expression of genes that encode iron binding proteins are regulated at the 
transcriptional level.  
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Many transcriptional regulators are allosteric DNA binding proteins. 
Structurally, they typically have an effector binding domain and a DNA binding 
domain. The DNA binding domain of the transcription factor contains the DNA-
recognition elements required for a specific protein:DNA interaction. Allosteric 
regulation of transcription factors involves binding of a small ligand to a regulatory 
site/effector binding domain, distal from the DNA binding site. Small ligand binding 
is accompanied by a conformational change in the protein that alters the protein’s 
affinity in site specific DNA binding. The resulting protein:DNA interaction is critical 
for regulating transcription initiation. Transcription initiation is regulated by the 
action of two classes of transcription factors including activators and repressors. 
While activators enhance transcription initiation, repressors inhibit this process. The 
discussion below on the mechanism of allosteric control of transcription factors is 
focused on repressors. 
                                                                                                                                                                                                                                                                     
 The mechanisms of allosteric regulation of many transcriptional repressors 
have been determined. In the classical mechanism, repressors exist as preformed 
oligomers, and effector binding affects the affinity for DNA by altering the 
conformation of the DNA recognition elements in the repressor. Among the 
repressors that exhibit this mechanism are the lactose repressor (LacR), tryptophan 
repressor (TrpR), purine repressor (PurR) and nickel repressor (NikR). In the non-
classical mechanism, binding of the effector alters the self-assembly properties of the 
repressor. The resulting change in oligomeric state affects the binding affinity for 
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DNA. The diphtheria toxin repressor (DtxR), luecine responsive element (LrpA) and 
the biotin repressor (BirA) belong to this class of repressors.  
 
Allosteric regulation of the biotin repressor, BirA, follows the non-classical 
mechanism. As described in the section on Allosteric Regulation, the mechanism 
involves two coupled processes. Binding of the allosteric activator, bio-5’-AMP, to 
apoBirA drives dimerization that is followed by DNA binding. The ligand-bound 
BirA homodimer binds to a 40 base-pair, inverted palindromic sequence of the biotin 
operator (bioO) to repress transcription initiation at the two divergent overlapping 
promoters, Pa and Pb of the biotin operon (5, 6). The N-terminal DNA binding domain 
comprises a winged-helix-turn-helix (wHTH) motif that forms site-specific contacts 
with the DNA. While the recognition helix of the motif contacts the major groove of 
DNA, the wing extends into the minor groove. Alteration in the amino acid sequence 
of the recognition helix of the wHTH results in loss of repression at the biotin control 
region. A combination of solution techniques, including DNase I footprinting, 
methylation protection and hydroxyl radical footprinting, have revealed the contact 
regions between the BirA dimer and the biotin operator (35). Two of the regions 
include the N-terminal DNA binding domain of each monomer that interacts with the 
two 12 base-pair termini of the 40 base-pair biotin operator sequence.  
  
The structural mechanisms by which effector binding alters the protein:DNA 
interaction has been studied in various systems. In some transcriptional repressors the 
ligand binding site is located at the interface. Binding of the ligand alters the 
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structural features of the protein:DNA interface, thereby affecting transcriptional 
regulation. In others, the ligand binding site is located distal to the protein:DNA 
interface. Here, ligand binding creates a new structural module in the repressor for 
interaction with DNA. A brief review of two examples is presented to illustrate these 
distinct structural mechanisms and to provide a context for the research performed in 
chapter three.  
 
1. Tryptophan Repressor 
The Trp repressor, TrpR, regulates transcription of the trpABCDE operon, 
which encodes the enzymes utilized in the biosynthesis of L-tryptophan from 
chorismate, in response to L-tryptophan (58). Each monomer consists of a N-terminal 
helix-turn-helix DNA binding domain and a C-terminal domain. Three α-helices of 
the C-terminal domain of each monomer pack against each other to form the dimer 
interface that is stabilized by a hydrophobic core. TrpR functions as a homodimer in 
binding to its operator sequence and is allosterically activated by tryptophan binding.  
 
Comparison of the structures of apoTrpR and holoTrpR determined by x-ray 
crystallography and NMR (59-62) have enabled some understanding of the allosteric 
activation mechanism of the tryptophan repressor by L-trp. Based on structural and 
biochemical analyses, different mechanistic models have been proposed. In one, 
binding of L-trp to the protein dimer acts like a wedge between the core domain and 
the DNA binding domain, thereby positioning the recognition helix of each monomer 
in the proper geometry for tight, complimentary alignment with the two operator half-
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sites (63). In another, L-trp binding induces complete folding of portions of the helix-
turn-helix domain of TrpR which increases the affinity for DNA.  
 
While the mechanistic models previously proposed were based on comparison 
of structures of apo- and holo-repressors, structural data on the repressor:DNA 
complex has provided a more complete understanding of the mechanism. TrpR was 
the first transcription factor for which a crystal structure was obtained for the 
repressor:operator complex (64). The tryptophan repressor interacts with DNA in the 
absence/presence of L-trp and the L-trp binding site is located at the protein:DNA 
interface. In the absence of tryptophan, the protein:DNA interaction is non-specific. 
ApoTrpR binds two L-tryptophan molecules prior to site-specific binding to the 
operator. Sequence-specific holorepressor binding is distinguished from the non-
specific aporepressor binding by a 6500 fold difference in dissociation constants (65). 
The structural mechanism of effector-induced changes in the protein:DNA interaction 
has been determined by structural and biochemical methods. Structural determinants 
important to the repressor:operator interaction have been identified (59). The 
protein:DNA interaction between the tryptophan repressor dimer and DNA is 
governed largely by electrostatics. TrpR carries a relatively large net negative charge 
which results in repulsive interactions with the DNA. Structurally, the tryptophan 
binding pocket located at the repressor:operator interface undergoes an enhancement 
in positive potential upon effector binding, as compared to the aporepressor. This is 
supported by biochemical studies with tryptophan and its analogs that indicate an 
overall change in electrostatics upon effector binding. Direct contacts between the 
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effector and the DNA play an essential role in altering the electrostatic details of the 
interaction (66). In this system the allosteric ligand participates in the binding 
mechanism through direct alterations in the structural features of the interface. 
    
2. Nickel Repressor 
In the presence of nickel, the nickel repressor, NikR, represses transcription of 
the operon nikABCDE that encodes the nickel importer/permease (67, 68). 
Biochemical studies have shown that one nickel (II) ion binds each subunit of the 
homotetramer with high affinity in the picomolar concentration regime (69, 70). 
Nickel binding enhances the NikR affinity for its 28-base pair palindromic operator 
sequence by 250 fold. High resolution structures of apoNikR and metal bound NikR 
have been determined by x-ray crystallography (71, 72). The structure of apoNikR 
from E. coli reveals a modular domain architecture, with two dimer ribbon-helix-
helix (RHH) DNA binding domains flanking a tetrameric metal-binding domain 
(MBD). Comparison of the apo- and metal-bound repressor structures reveals a 
disorder-to-order transition of a flexible loop in the nickel binding site upon binding 
metal. Preliminary structural and biochemical results provide insight into the 
mechanism of activation of NikR by metal ions. 
 
Recent structural approaches undertaken to elucidate the structural mechanism 
of nickel-induced DNA binding of NikR reveal formation of a new structural module 
upon metal binding that directly interacts with DNA. Formation of the NikR-operator 
complex results in extensive polar interaction between the repressor and DNA. These 
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include specific and non-specific interaction from the RHH domain and non-specific 
interaction from the MBD (72) (Figure 6). The structure of the NikR 
repressor:operator complex  indicates that the RHH DNA binding domains interact in 
the standard mode with the DNA backbone. They form specific contacts via hydrogen 
bonds between the side chain of two residues of a β-sheet and the nucleotide bases in 
the major groove of DNA. Mutation of these residues results in defective NikR 
binding to the operator, thus supporting the observation (68). The non-specific 
interactions contributed by the RHH domain include about 14 nonspecific interactions 
with the DNA backbone. Although biochemical measurements have not been 
performed to test these non-specific interactions, they have previously been observed 
in other members of the RHH family (73, 74). These non-specific interactions serve 
to anchor the domain to the DNA by properly orienting the specificity-determinants 
of the β-sheet of the RHH in the major groove of the DNA. Additionally, nickel 
binding induces a disorder-to-order transition of two loops in the metal binding 
domains. This change in conformation results in non-specific interactions between the 
side chains of two positively charged residues within the loops and the DNA 
backbone. Although these structural observations have not yet been assessed by 
biochemical methods, these data suggest formation of a new structural module upon 
metal binding in NikR that contributes to the structural mechanism of the 
protein:DNA interaction. 
The third chapter of the thesis is focused at elucidating the structural 
mechanism of allosteric activator induced interaction of the biotin repressor and its 
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site-specific DNA sequence. In particular, the role of flexible loops involved in ligand 
binding and dimerization are examined for their role in direct interaction with DNA. 
 
C. Regulating protein function via protein:protein interaction 
The functional properties of many proteins are regulated in response to 
cellular requirements. Regulation of protein function can occur through interaction 
with another protein partner. For example, the E. coli global transcription regulator 
MIc, modulates production of glucose-specific PTS (phosphotransferase system) 
components (75). Glucose-bound MIc activates transcription of the ptsG gene that 
encodes glucose permease. In turn, at high glucose concentration, an increased 
production of glucose permease controls MIc-dependent gene expression. The 
glucose-bound enzyme, in its non-phosphorylated state, sequesters MIc in a 
protein:protein interaction, rendering it unavailable for transcription activation (76). 
Many enzymes like glucose permease can control gene expression in response to the 
availability of their substrates/effector through interaction with transcription factors. 
Table 1. includes some examples from E. coli. 
  
  In many biological regulatory processes protein function is modulated via 
exchange of one protein partner for another. For example, the transcription factor 
CHOP can associate with itself or other members of the C/EBP family. The choice of 
protein partner dictates transcriptional regulation at different target genes (77, 78). 
Similarly, the choice of a dimerization partner of proteins that belong to the 





Table 1. Control of Gene Expression by Enzyme-Transcription Factor Interaction 
Enzyme/ catalyzed 
reaction 
Substrate/Effector Target Protein 
PtsG, Glucose permease Glucose MIc (76) 
MalK, ATP binding 
subunit of the maltose 
transporter 
Maltodextrins, Maltotriose  MalT (80) 
PyrH, UMP kinase Pyrimidines PepA (81) 
DhaL, DhaK, 
dihydroxyacetone kinase 






Figure 6. Structural Determinants of the NikR-Operator DNA Interaction (72). 
Displayed are the specific contacts of the RHH domain (cyan) and the non-specific 
contacts of the MBD loops (yellow) with the operator in the NikR:operator complex. 
Model was generated using the program MolMol (28) with Protein Data Bank file 







different genes (79). Several analogous systems in which a single protein switches 
between alternative interactions to regulate function have been identified. 
 
Control of a portein’s biological function can occur through the use of the 
same surface of one protein in alternative protein:protein interactions. For instance, 
HAUSP (Herpesvirus-associated ubiquitin-specific protease) interacts with p53 
tumor-suppressor and with MDM2 to regulate the p53-MDM2 pathway. MDM2 is an 
E3 ubiquitin ligase that ubiquitylates itself and p53, thereby serving in a complex 
auto-regulatory feedback loop (83, 84). HAUSP serves in deubiquitylation in its 
interaction with both proteins (85, 86). The HAUSP-p53 interaction stabilizes p53 
resulting in p53-dependent apoptosis. By contrast, the HAUSP-MDM2 complex leads 
to suppression of MDM2 activity, in turn, stabilizing p53.  Although the regulation of 
this pathway via two distinct protein:protein interactions is complex, an examination 
of the structures indicates that both interactions utilize the same surface groove in the 
N-terminus of HAUSP (87). Another example is plakoglobin (γ- catenin), which 
interacts with desmosome proteins (Dsg and Dsc) belonging to the cadherin 
superfamily, to enable desmosome (intracellular junction) assembly. Alternatively, 
plakoglobin can interact with α-catenin to from adherens junctions. The regulation of 
distinct junction assemblies by plakoglobin occurs via protein:protein interactions 
that use the same surface in the C-terminal domain of plakoglobin (88). A common 
theme in such systems is utilization of a single protein surface in alternative 
protein:protein interactions, thereby making the functions mutually exclusive. 
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 In some systems, alternative protein:protein interactions regulate distinct 
functional features of a protein. The same surface of one protein is utilized in specific 
interaction with different protein partners, thereby rendering them mutually exclusive. 
One of the best studied systems is β-catenin. β-catenin functions as a transcriptional 
coactivator and in cell-cell adhesion (89). As a coactivator of transcription initiation 
β-catenin interacts with members of the T-cell factor (Tcf)/lymphoid enhancer factor 
(LEF) family of transcription factors (90). Alternatively, β-catenin interacts with 
cadherins in its cell adhesion function. The functional switch in β-catenin is 
controlled by the availability of the protein. Structural data indicate that the same 
surface of β-catenin is used to form complexes with E-cadherin and the transcription 
factor, Tcf-3 (Figure 7). In the former interaction the armadillo repeat sequence of β- 
catenin, interacts with the cytoplasmic catenin binding domain of E-cadherin. The 
same surface of the armadillo repeat sequence interacts with the amino terminal 
segment of the Tcf-3. Close inspection of the structures reveal similar chemistries at 
the two interfaces (91, 92). The ability of a single protein to form interactions with 
two different protein partners with promiscuity and specificity is remarkable. 
Although there is evidence in many systems that such alternate functions are mutually 
exclusive, an understanding of their mechanisms of regulation requires elucidation of 
the structural, thermodynamic and kinetic features of formation of alternative 
protein:protein interactions. 
 
  The biotin repressor/ biotin holoenzyme ligase, BirA, which is a bifunctional 
protein provides another example in which the same surface of one protein is used for 
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alternative protein:protein interactions. Extensive structural, thermodynamic and 
kinetic studies have been performed to investigate the functional switch in BirA. The 
fourth chapter of the thesis focuses on investigating the structural features of two 
mutually exclusive interactions that dictate the functional switch.  
 
 The mechanism of control of the functional switch of holoBirA from 
transcription repressor to biotin ligase has been extensively studied. As described 
earlier, binding of the intermediate, bio5’-AMP to BirA populates the activated 
monomer, holoBirA. HoloBirA participates in homodimerization or 
heterodimerization with the acceptor protein, apoBCCP, a subunit of the acetyl-CoA 
carboxylase enzyme. In vivo and in vitro data indicate that the concentration of the 
acceptor protein plays an important role in control of the functional switch (93, 94). 
In vitro studies show that apoBCCP engages holoBirA for biotin transfer, thereby 
depleting the holoBirA pool available for homodimerization. Thermodynamic 
measurements for formation of the homodimer and heterodimer reveal that they are 
isoenergetic, indicating a kinetically controlled switch (95, 96).     
 
 Structurally, the functional switch reflects formation of two mutually exclusive 
processes. A structural model of holoBirA-apoBCCP has been formulated and is 
supported by results of biophysical and biochemical studies of BirA and BCCP 




Figure 7.Structural Models of β-Catenin in alternative protein:protein interactions.  
(A) Complex of β-catenin and N-terminal segment of the transcription factor, Tcf-3.  
(B) Complex of β-catenin and the cytoplasmic domain of E-cadherin. Models were 
generated using the program MolMol (28) with Protein Data Bank files 1G3J for (A) 






holoBirA homodimer and the hypothetical structural model of the holoBirA-
apoBCCP complex reveals that the same surface of BirA is utilized in both 
protein:protein interactions. The homodimer is formed via an antiparallel interaction 
between the same β-strand of the central domain of each holoBirA. By contrast the 
heterodimer interaction uses the same β-strand of holoBirA in a parallel interaction 
with a β-strand of apoBCCP to form an extended β-sheet. Although the same surface 
of BirA is utilized for homodimerization and heterodimerization, there is evidence 
that the chemistries of the two interfaces are distinct. In order to examine the 
structural features of alternative protein:protein interactions of BirA, in the fourth 
chapter of the thesis, the flexible loops involved in intermediate binding and 
homodimerization are investigated for their roles in heterodimerization.  
 
D. Organization of the Dissertation 
 The first chapter of this dissertation is an Introduction that provides concepts 
and a literature review of specific systems with respect to allostery, allosteric 
regulation of transcription factors and regulation of protein function via 
protein:protein interactions. 
 
The second chapter presents work that was published in the Journal of 
Molecular Biology. The work focuses on investigating the role of a hydrophobic 
cluster in a flexible loop of the biotin repressor that orders over the adenine ring in the 
ligand-induced allosteric response in the protein. The approach involved site-directed 
mutagenesis of residues in the hydrophobic cluster. The mutant proteins were 
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subjected to detailed thermodynamic analysis of small ligand binding and 
dimerization properties by isothermal titration calorimetry and sedimentation 
equilibrium techniques. Further, structural probing by partial proteolysis and heat 
capacity measurements by isothermal titration calorimetry were performed to assess 
the affect of mutations in the cluster on ligand-linked folding of the flexible loop. 
Overall, the results indicate that formation of the hydrophobic cluster is critical to a 
disorder-to-order transition of the loop and that this transition is integral to the 
allosteric response in BirA     
  
The third chapter describes and tests predictions of a model for the repressor 
dimer:biotin operator complex. The model was entirely constructed and proposed by 
Dr. Zachary A. Wood, who is presently at the University of Georgia. It was generated 
based on combined structural and biochemical data. The aim of this work is to 
investigate the role of the effector in influencing the structural features of the 
protein:DNA interface of the E. coli biotin repressor dimer and its specific DNA 
sequence, bioO.  The model predicts electrostatic interactions between positively 
charged residues of the effector binding loops of BirA and the backbone of the biotin 
operator backbone. Proteins in which these positively charged residues were changed 
to alanine were subjected to the DNase I footprinting titrations to asses their bioO 
binding properties. These results revealed that the energetics of dimer:DNA complex 
assembly were unaffected upon abolition of all putative electrostatic contacts. 
Overall, contrary to predictions based on the structural model, the effector binding 
loops do not directly interact with the DNA. 
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 The fourth chapter describes work that focused on the alternative 
protein:protein interactions that control the functional switch in BirA. The structural 
determinants important to BirA homodimerization and heterodimerization with 
acceptor protein, apoBCCP, were investigated using a combination of mutagenesis 
and biochemical methods. Single site mutation of residues that directly disrupt the 
protein:protein interface and those that perturb the thermodynamic coupling between 
intermediate binding and homodimerization were investigated for defects in 
heterodimerization. The ligand binding and homodimerization properties of select 
mutant proteins were previously characterized by another graduate student in this 
laboratory, Dr. Keehwan Kwon. Results indicated an overlap in structural features 
important to both protein:protein interactions. 
 
 The fifth chapter summarizes how the results obtained in this research have 
provided an understanding of the structural basis for multi-functionality in the E. coli 
biotin repressor/biotin ligase. A discussion of future prospects for research is also 
included in this section. The final chapter provides details on the Materials and 









II. Nucleation of an Allosteric Response via Ligand-induced Loop 
Folding  
A. Introduction 
Allostery is ubiquitous in cellular processes including metabolism, signal 
transduction, and transcription regulation (14, 15). Consequently, allosteric control 
operates in a broad range of macromolecules including oligomeric metabolic enzymes 
(aspartate transcarbamylase) (99) chaperonin machines (GroEL) (100), transcription 
regulatory proteins (lactose repressor) (101), multi-domain signal transduction 
proteins (N-WASP) (102), and small molecule-activated riboswitches (Adenine 
riboswitch) (103). Understanding allostery requires elucidation of the mechanism(s) 
by which a signal associated with small ligand binding or post-translational 
modification is relayed through the macromolecule to effect functional changes. In 
many cases this signal is transmitted over a large distance. One route to understanding 
allostery in biological macromolecules is experimental determination of the 
significance of structural and dynamic changes in the macromolecule for the 
functional response. 
 
The Escherichia coli repressor protein, BirA, is the central component of the 
biotin regulatory system and serves as an excellent model for the study of allostery. 
BirA is a bifunctional protein that is both a key metabolic enzyme and a repressor of 
transcription initiation (2, 3). As an enzyme, BirA, or biotin holoenzyme ligase, 
catalyzes the two-step biotinylation of the Biotin Carboxylase Carrier Protein 
(BCCP), a subunit of the acetyl-CoA carboxylase, which catalyzes the first 
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committed step of fatty acid biosynthesis. BirA first catalyzes synthesis of biotinyl-
5’-AMP (bio-5’-AMP) from its substrates biotin and ATP and then transfers the 
biotin moiety of the intermediate to the ε-amino group of a specific lysine residue on 
BCCP (4). Biotin, when linked to BCCP, is the transient carrier of a carboxylate 
group in its transfer from the donor, bicarbonate, to the acceptor, acetyl-CoA, and 
thus plays the role of an essential cofactor in the first committed step of fatty acid 
biosynthesis. As a transcription repressor, the BirA homodimer binds the biotin 
operator, bioO, thereby preventing transcription initiation at the biotin biosynthetic 
operon (5-7). It is not the apoBirA monomer, but rather the holo- or adenylate-bound 
dimer that is the active species in biotin operator binding. Hence, bio-5’-AMP is both 
the corepressor of BirA in its transcription repression function and the intermediate in 
its catalysis of biotin transfer to the BCCP subunit of acetyl-CoA carboxylase. 
 
ApoBirA, the unliganded form of BirA, is monomeric, as evidenced by its 
crystal structure and gel filtration and sedimentation equilibrium studies (18). The 
protein is composed of three domains. The N-terminal DNA binding domain adopts a 
winged-helix-turn-helix motif that directly contacts the DNA in the repression 
complex. The central domain is organized into a 7-stranded mixed β-sheet packed 
against 5 α-helices, and five surface loops of which four are partially disordered. This 
domain contains the catalytic site and biochemical data indicate its direct role in 
dimerization and indirect role in DNA binding. The C-terminal domain contains a β-
sandwich motif and structural studies indicate its involvement in repressor 
dimerization (30). 
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The mechanism of allosteric activation of BirA involves corepressor-linked 
repressor dimerization. Binding of the bio-5’-AMP to apoBirA is positively coupled 
to repressor dimerization (Figure 8). This mechanism of allosteric activation of BirA 
has been studied extensively using equilibrium thermodynamic and kinetic techniques 
(5, 16-18, 32, 35). Sedimentation equilibrium measurements indicate that adenylate 
binding enhances BirA dimerization energetics by -4 to -5 kcal/mol (17, 27). Kinetic 
and equilibrium thermodynamic measurements of repression complex assembly 
reveal a two-step process of dimerization followed by DNA binding (16). Finally, 
comparison of apoBirA and holoBirA in dimerization and the two-step assembly of 
the repression complex indicates that allosteric activation is thermodynamically 
centered in the dimerization step (27). Therefore, elucidation of the allosteric 
mechanism in BirA requires determination of the structural and dynamic changes in 
the BirA monomer that accompany activation of dimerization by bio-5’-AMP. 
 
The magnitude of the allosteric response in BirA can be modulated using 
analogues of the physiological effector, bio-5’-AMP. Based on their ligand binding 
properties and abilities to promote repressor dimerization and bioO binding, these 
small ligands are categorized as weak and strong allosteric activators. Bio-5’-AMP 
and its analog biotinol-AMP (btnOH-AMP) are strong allosteric activators while d-
biotin, a substrate in bio-5’-AMP synthesis, and the sulfamoyl analog of bio-5’-AMP 





Figure 8: Allosteric activation of the biotin repressor by its physiological corepressor, 
bio-5'-AMP. Binding of the ligand is positively coupled to repressor dimerization. 
The resulting dimer subsequently binds site-specifically to the biotin operator 
sequence, bioO. ApoBirA refers to the unliganded protein and holoBirA is the bio-5’-
AMP-bound species. Kb, Kdim, and KbioO refer to the equilibrium constants governing 






enhancement of dimerization, btnSA binding affords an enhancement of -1 kcal/mol 
(104). The designation of weak effector for biotin is based on its modest (-1 
kcal/mole) enhancement of bioO binding. High resolution structures of the repressor 
bound to the weak activator, biotin, and strong activator, btnOH-AMP, have been 
determined by x-ray crystallography (30, 31). In both structures the repressor is 
dimeric, with the dimerization interface located at the central domain of each 
monomer and formed by side-by-side alignment of β-sheets to form an extended β 
sheet.  
 
Comparison of the structures of apoBirA, and the BirA-biotin and BirA-
btnOH-AMP complexes provides clues about conformational changes that may be 
important for allosteric activation of the BirA monomer. In both dimer structures, 3 of 
the 4 partially disordered loops in apoBirA are ordered and form part of the dimer 
interface. One of these three interface loops, referred to as the biotin-binding loop or 
BBL, is folded over the biotin moiety in both structures. While the dimer interface of 
the BirA-biotin and the BirA-btnOH-AMP complexes bear these similarities, the 
energetic difference between a weak and strong activator-induced dimerization, is 
large (-3 kcal/mol). Further comparison of the two dimers reveals some differences. 
For example, consistent with its greater stability, the dimer interface in the adenylate-
bound species is larger and extends to the C-terminal domain. However, the greatest 
structural difference is not found at the dimer interface. Rather, it is the ordering of a 
fourth flexible loop in the adenylate-bound dimer, which remains disordered in the 
BirA-biotin dimer structure. This loop, consisting of residues 212-234, is distal to the 
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dimer interface and is folded over the purine ring of the adenylate moiety (31). It is 
therefore referred to as the adenylate binding loop or ABL (Figure 9A). 
 Details of the ABL structure in the adenylate-bound dimer provide insight into 
one structural feature that may be pivotal to the allosteric response. Despite the 
nomenclature, residues in the loop form no direct interactions with the adenylate 
portion of the corepressor. With the exception of residue E228, the hydrophilic side 
chains of ABL residues interact with solvent. Hydrogen bonding interactions are 
observed between E228 and the R182 side chain. One striking structural feature is a 
hydrophobic cluster formed by side chains of three loop residues, V214, V219, and 
W223, which is assembled on one face of the adenine ring (Figure 9B). Given that 
formation of the cluster is linked to binding of the adenylate it is logical to infer that it 
may be integral to the disorder-to-order transition that accompanies adenylate 
binding. Moreover, since binding of the weak activator, biotin, is not coupled to this 
folding process, it is reasonable to hypothesize that the full allosteric response 
requires the formation of the cluster. In this study detailed thermodynamic analyses 
were performed to determine the contribution of the cluster to the allosteric activation 
process in BirA. Single amino acid replacements of residues in the hydrophobic 
cluster were constructed and resulting purified mutant proteins were analyzed for 
ligand binding and corepressor-induced dimerization. The mutant proteins were also 
subjected to structural probing using subtilisin-mediated partial proteolysis. The 
combined results indicate that disruption of the hydrophobic cluster compromises 
effector-induced folding of the ABL and that the folding is critical to allosteric 
















Figure 9. (A) Structure of the BirA: btnOH-AMP complex. The ligand-bound dimer 
complex is formed with the dimerization interface located at the central domain of 
each monomer. The biotin binding loop is located at the dimer interface, while the 
adenylate binding loop is distal to this interface and folds over the adenylate moiety 
of btnOH-AMP. (B) Stereo view of the ligand binding site with the hydrophobic 
cluster highlighted: the biotin binding loop (BBL) is shown in blue and is ordered 
over the biotin moiety. Represented in grey is the ABL folded over the adenylate 
moiety. The side chains of the hydrophobic cluster, V214 (green), V219 (red) and 
W223 (yellow), are shown as space filling models. The figures were generated using 













1. Biotin binding to BirA variants: 
 Structural data indicate that the biotin binding (BBL) and the adenylate 
binding (ABL) loops undergo a disorder-to-order transition upon small ligand binding 
(31). Previous studies reveal that mutations in the biotin binding loop can lead to 
decreased affinity for both biotin and bio-5’-AMP (32). Isothermal titration 
calorimetry was used to investigate the functional effects of mutations in the 
adenylate binding loop on small ligand binding. Biotin binding measurements were 
performed to investigate the possible interaction between the BBL and ABL in 
substrate binding. Titrations with both bio-5’-AMP as well as its analogue btnOH-
AMP were also performed. While the structural data available for the latter ligand 
allows correlation of functional effects with structure, the former ligand is the 
physiological effector. 
 
 Titrations of variant repressors with biotin were performed using the standard 
direct calorimetric titration method. Since dimerization of the biotin-bound repressor 
occurs in the millimolar range of concentration, no contribution of coupled 
dimerization to the measurements need be considered.  Calorimetric data were 
obtained from titrations in which 25-10 µl injections of a 20 µM concentrated biotin 
stock were injected into a 2 µM protein sample. A typical ITC profile for biotin 
binding to BirA in standard buffer (10 mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 
oC), 200 mM KCl, 2.5 mM MgCl2) is shown in Figure 10A. Data of similar quality 
were obtained from titrations of each variant with biotin. The best-fit curve was 
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obtained from nonlinear least-squares analysis of the data using a single-site binding 
model (Origin 7.0). Consistent with previously published data, the equilibrium 
dissociation constant for the wild type BirA·biotin interaction is 4.2 (± 0.3) x 10-8 M 
(29). Moreover, the binding is characterized by a large favorable enthalpy and an 
opposing unfavorable entropy (Table 2 and Figure 11A). As shown in Figure 11A and 
Table 2, the biotin binding properties of the ABL variants are similar to those 
measured for the wild type protein.  
 
2. Bio-5’-AMP and BtnOH-AMP Binding to the ABL Variants 
 Titrations of BirA variant proteins with adenylate ligands were performed to 
determine effects of single amino acid replacements of the hydrophobic cluster on 
adenylate binding. Binding of both the physiological corepressor, bio-5’-AMP, and 
its analogue, btnOH-AMP, was measured. Previous studies revealed that both bio-5’-
AMP and btnOH-AMP bind very tightly to the wild type repressor with equilibrium 
dissociation constants of 4 (± 2) x 10-11 M and 1.5 (± 0.2) x 10-9 M, respectively 
(104).  These tight interactions necessitated use of the displacement titration method 
for measurement (Sigurskjold) (105) in which the protein is first titrated to saturation 
with the weaker binding ligand, biotin, followed by its displacement with the ligand 
that binds more tightly, either bio-5’-AMP of btnOH-AMP. By contrast, the affinities 
of the ABL variants for the two adenylate ligands are sufficiently weak to allow use 
of the direct titration method for determining the thermodynamic parameters 
governing the binding processes. In all cases the protein concentration used for the 
titration was sufficiently low to avoid any contribution of coupled dimerization to the 
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binding process. A representative titration is shown in Figure 10B. The data were 
analyzed using a single site model and the results are shown in Table 2 and Figures 
11B (btnOH-AMP) and 11C (bio-5’-AMP).  Each ABL variant exhibited adenylate 
binding properties distinct from those measured for the wild type repressor. All three 
ABL variants exhibited lower affinities for the adenylate ligands than does the wild 
type repressor with energetic penalties (∆∆Go) for btnOH-AMP binding ranging from 
0.8 to 1.8 kcal/mole. By contrast, the magnitudes of the ∆∆Go for bio-5’-AMP are all 
approximately 3 kcal/mole. Thus, while the defects measured for bio-5’-AMP and 
btnOH-AMP binding are not identical, they parallel one another. The partitioning of 
the ∆∆Go into enthalpic and entropic penalties is distinct for the three variants. For 
W223A the less favorable free energy associated with binding either ligand reflects 
only a loss in binding enthalpy.  Replacement of Val 214 or Val 219 with alanine 
resulted in more favorable binding enthalpy for each ligand and a sizable opposing 












Figure 10. Calorimetric titrations of BirA.  
(A) Direct titration of V214A with biotin. 25-10 µl volumes of 20 µM biotin solution 
were injected into 2 µM BirA. (B) Direct titration of BirA variant V214A with bio-5’-
AMP. 21 10 µL volumes of 20 µM bio-5’-AMP solution is injected into 2 µM BirA 
variant V214A. These experiments were performed at 20 °C in standard buffer [10 
mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 ˚C), 200 mM KCl, 2.5 mM MgCl2]. The 
best-fit curves obtained from non-linear least-squares analysis of these data using a 
















Figure 11. Thermodynamic profiles for binding of (A) biotin, (B) btnOH-AMP, and 
(C) bio-5’-AMP to WT-BirA and ABL variants. Each panel (left) shows enthalpic, 
∆H˚, and entropic, -T∆S˚, contributions to and Gibbs free energies of, ∆G˚ binding.  
Ligand structures are also shown (right). Note that the scale is different for btnOH-


























WT 4.3 (± 0.3) x 10-8             -9.84  ± 0.04 -19.4 ± 0.2 9.4 ± 0.2 0.91 ± 0.01 
W223A 4.7 (± 0.4) x 10-8  -9.8 ± 0.1 -19.6 ± 0.2 9.8 ± 0.2 0.83 ± 0.01 
V214A 3.8 (± 0.8) x 10-8              -9.9 ± 0.1 -19.5 ± 0.2 9.6 ± 0.2 0.85 ± 0.01 
Biotin 
V219A 3.8 (± 1.0) x 10-8  -10.0 ± 0.2 -19.4 ± 0.5 9.3 ± 0.2 0.91 ± 0.01 
WT 1.5 (± 0.2) x 10-9  -11.8 ± 0.1 -9.9 ± 0.1 -2.1 ± 0.1 0.89 ± 0.01 
W223A 3.8 (± 0.6) x 10-8           -10.0 ± 0.1 -8.0 ± 0.1 -2.05 ± 0.04 0.85 ± 0.01 
V214A 6.9 (± 1.1) x 10-9  -10.9 ± 0.1 -13.1 ± 0.9 2.2 ± 0.7 0.88 ± 0.01 
btnOH-
AMP 
V219A 5.8 (± 1.0) x 10-9  -11.0 ± 0.1 -13.3 ± 0.9 2.3 ± 0.8 0.82 ± 0.01 
WT 3.9 (± 1.9) x 10-11 -13.9 ± 0.4 -12.3 ± 0.9 -1.6 ± 0.9 0.91 ± 0.01 
W223A 1.4 (± 0.9) x 10-8 -10.5 ± 0.5 -9.4 ± 0.9 -1.0 ± 1.0 0.93 ± 0.01 
V214A 9.7 (± 1.6) x 10-9 -10.7 ± 0.1 -15.9 ± 1.1 6.1 ± 1.5 0.88 ± 0.01 
bio-5’-
AMP 
V219A 6.9 (± 2.0) x 10-9 -10.9 ± 0.2 -15.1 ± 2.0 4.2 ± 1.8 0.90 ± 0.01 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in the Materials and 
Methods section. The reported values represent the average of at least two 
independent titrations with standard deviation. a. Values of Kb, ∆H
o, and n were the 
best-fit values obtained from nonlinear least squares analysis of the titration data to a 
simple binding model using Origin. b. The values of the Gibbs free energy, ∆Go, were 
calculated using the expression ∆Go=RTlnKb and those of -T∆So were calculated 
using the relationship ∆Go=∆Ho-T∆So. 
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3. Heat Capacity Changes Associated with Small Ligand Binding 
In order to determine the heat capacity changes associated with small ligand 
binding to the ABL variants, the temperature dependence of the binding enthalpy was 
measured. These measurements were accomplished using the Total Association at 
Partial Saturation (TAPS) technique in which the protein is placed in the sample cell 
and, following the initial 2 µL control injection, five injections of ligand are made 
under conditions in which all ligand associates with protein (106) (Figure 12). These 
five injections are followed by a large volume injection that is sufficient to saturate 
the protein with ligand. Finally, several post saturation injections are made in order to 
determine the heat of ligand dilution. Since the amount of ligand added in the final 
injections is identical to that used in the first five, subtraction of the average 
integrated signal associated with these final injections from the heat associated with 
each of the first five yields the corrected heat of binding of the ligand to the protein. 
These measurements were made for binding of wild type and the ABL variant 
proteins to biotin, biotinol-5’-AMP and bio-5’-AMP at temperatures ranging from 5-
20 oC. Dimerization of holoBirA becomes more favorable with increasing 
temperature (107). Therefore, in order to avoid any contribution of protein-protein 
interactions to the measured enthalpy, the temperature range at the high end was 
limited to 20 oC. The results are shown in Figure 13 along with the best-fit lines 
obtained from linear regression of the dependence of the measured heat on 
temperature. The resolved values of the heat capacity associated with the ligand 
binding processes are shown in Table 3. Consistent, with the results of the full 
titrations, the heat capacity associated with biotin binding to the mutants is identical 
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to that measured for the wild type repressor (Figure 13, Table 3). However, 
differences are observed for the two adenylate ligands. As evidenced by the shallower 
slopes in the enthalpy versus temperature profiles, the negative heat capacity changes 
measured for btnOH-AMP binding to the BirA mutants are consistently smaller in 
magnitude than those measured for the wild type protein (Table 3). The results 
obtained for bio-5’-AMP are more complex with the enthalpy change associated with 
the W223A mutant binding exhibiting a nonlinear dependence on temperature (Figure 
13). However, as observed with btnOH-AMP, bio-5’-AMP binding to the V214A and 
V219A mutants is accompanied by a negative heat capacity change that is smaller in 
magnitude than that measured for the wild type repressor (Figure 13, Table 3). 
 
4. Dimerization of Adenylate-bound Repressor Variant Proteins 
 Bio-5’-AMP binding promotes binding of BirA to the biotin operator by 
enhancing repressor dimerization. Results of previous studies indicate that while 
apoBirA dimerizes weakly in the millimolar concentration range, the BirA-bio-5’-
AMP complex exhibits relatively tight dimerization with a KD in the micromolar 
range of concentration. Thus the coupling free energy for dimerization associated 
with bio-5’-AMP binding to apoBirA is –4.0 kcal/mole. As indicated in the 
Introduction, structures of both the BirA:biotin and BirA:btnOH-AMP complexes are 
dimeric. However, while biotin is a weak allosteric activator, btnOH-AMP is nearly 
equivalent to bio-5’-AMP in its ability to drive repressor dimerization. For the wild 
type repressor dimerization of the btnOH-AMP complex is energetically more 





Figure 12. Titrations of BirA V214A with bio-5’-AMP under conditions of total 
association at partial saturation. The experiment was performed in standard buffer at 
15 °C.  A 2 µM protein solution was titrated with a 20 µM bio-5-AMP solution. The 
first 2 µL injection was followed by 5 x 5 µL injections, one 150 µL injection, and 
finally, 8 x 5 µL injections. The averaged integrated heat of the last eight injections 
provide the enthalpy of ligand dilution and was subtracted from the integrated heat of 
injections 2 through 6 to obtain five measures of corrected binding enthalpy of the 





Figure 13. Heat capacity changes for binding of  (A) biotin, (B) btnOH-AMP, and (C) 
bio-5’-AMP to WT-BirA and ABL variants. A plot of the temperature dependence of 
the binding enthalpy for (▼) WT-BirA, () V219A, (♦) V214A and (O) W223A 
with each ligand. Experiments were performed under conditions of total association at 
partial saturation as described in Figure 12. 
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Table 3. Heat Capacity Changes Associated with Ligand Binding to ABL Variants. 
Ligand BirA Variant ∆C˚p (cal-mol/K) 
Biotin Wild Type -270 (± 30) 
 W223A -310 (± 30) 
 V214A -290 (± 40) 
 V219A -296 (± 23) 
btnOH-AMP Wild Type -340 (±  8) 
 W223A -150 (± 30) 
 V214A -240 (± 50) 
 V219A -240 (± 50) 
bio-5’-AMP Wild Type -170 (± 30) 
 W223A N.Da 
 V214A -80 (± 20) 
 V219A -40 (± 20) 
 
All measurements were performed using the TAPS method in Standard Buffer 
adjusted to pH 7.50 ± 0.02 at the working temperature. The reported heat capacity 
changes were obtained from linear least squares analysis of the temperature-
dependence of the binding enthalpy, ∆Ho. a. The heat capacity change for this binding 




the energetic enhancement of dimerization associated with biotin binding is, within 
error, zero. A major difference between the two structures is the folding of the ABL 
around the adenylate moiety in the adenylate-bound species. The ITC results 
presented above indicate that all three ABL variants are defective in adenylate 
binding. The dimerization properties of each variant bound to btnOH-AMP and bio-
5’-AMP were measured by sedimentation equilibrium in order to determine the 
effects of the mutations on the coupling of small ligand binding to dimerization. 
 
Sedimentation equilibrium measurements were performed at three loading 
concentrations of each complex and the samples were subjected to centrifugation at 
three rotor speeds. In all cases the concentrations of both ligand and protein were 
sufficiently high to ensure saturation of the protein with ligand.  Figure 14A shows 
results of data obtained for the BirA.btnOH-AMP complex. The data were first 
analyzed using a single species model in order to obtain the average molecular weight 
of the complex. In all cases single species analysis indicated protein self-association. 
The data were then subjected to global analysis using a monomer-dimer self-
association model to resolve the dimerization constants. The quality of each fit was 
assessed from the magnitude of the square root of the variance of the fit and the 
residual plots. The dimerization free energy of the wild-type repressor bound to each 
of the adenylates is in excellent agreement with previously reported values (17, 29). 
Results obtained with the ABL variants indicate in all cases defects in dimerization 
relative to the wild type repressor. The resolved equilibrium dissociation constants for 
dimerization of the btnOH-AMP-bound variants differ from those measured for the 
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wild type protein by 1.8 to 2.7 fold (Table 4). Defects in dimerization of the bio-5’-
AMP-bound variants are greater in magnitude and the equilibrium dissociation 
constants for dimerization differ from 4.7 to 10.7 fold (Table 4). As shown in Figure 
14B, while the magnitude of ∆∆GDim for the btnOH-AMP-bound variants ranges from 
0.4 to 0.6 kcal/mole, it ranges from 0.9 to 1.5 kcal/mole for the bio-5’-AMP-bound 
species.  
 
5. Probing Structural Consequences of the Mutations by Partial Proteolysis 
 The BirA.btnOH-AMP structure reveals that the ABL undergoes a disorder-
to-order transition concomitant with adenylate binding. A striking feature of the 
folded ABL is the hydrophobic cluster formed by residues V214, V219, and W223. 
We have hypothesized that folding of the ABL and the associated formation of this 
cluster is important for the allosteric response in BirA. Results of ligand binding and 
dimerization measurements performed on the ABL variants indicate functional 
defects. These defects in dimerization are consistent with reduced allosteric responses 
in the variants. Partial proteolysis measurements were performed to determine if these 
functional defects are correlated with defective ligand-induced folding of the ABL. 
 
Previously, the kinetics of subtilisin-catalyzed proteolysis of WT BirA were 
measured in the absence and presence of ligands to investigate ligand-linked 
conformational changes in the adenylate binding loop. Initial subtilisin cleavage 
occurs between residues 217 and 218 in the ABL and gives rise to two products of 25 
and 10 kDa (108). The time dependence of the cleavage can be measured by 
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subjecting the cleavage products to SDS-polyacrylamide gel electrophoresis. The 
amount of intact BirA present at specific time points after addition of protease is 
quantitated by densitometry of a Coomassie brilliant blue-stained gel as shown in 
Figure 15A. The apparent rate of cleavage of the protein is obtained from analysis of 
the densitometry data using a pseudo first-order kinetic model for the reaction. A 
graphical representation of the data and analysis are shown in Figure 15B. For the 
wild type repressor, binding of the weak activator biotin results in a 2-fold decrease in 
the rate of proteolysis relative to unliganded repressor, while binding of the strong 
activator bio-5’-AMP results in a 10-fold decrease (108). The apparent rates of 
proteolysis of each repressor ABL variant were measured in the absence of ligand and 
in the presence of biotin and bio-5’-AMP. The results shown in Table 5 indicate 
differences in the cleavage rate for each variant in the absence of ligand relative to 
that measured for the wild-type repressor. More significantly, replacement of residues 
in the hydrophobic cluster resulted in decreased levels of adenylate-linked protection 















Figure 14. (A) Absorbance versus radial position for 45 µM W223A.btnOH-AMP at 
22,000 (◊), 26,000 (x) and 30,000 (o) rpm obtained in standard buffer at 20 ˚C. The 
best-fit curves were generated from global analysis using a monomer-dimer model of 
six data sets acquired at multiple loading concentrations and spun at three speeds. The 
residuals of the fit for each data set shown are provided in the bottom panels. (B) Free 
energy of dimerization, ∆G˚Dim, of each ABL variant complexed with btnOH-AMP or 












Table 4. Dimerization Properties of Complexes of the BirA ABL Variants 
Ligand BirA Variant Kdim (M) ∆G˚dim (kcal/mol) 
WT 2.7 ( ± 0.8) x 10-5 -6.1 ± 0.2 
W223A 5 ( ± 1) x 10-5 -5.7 ± 0.2 
V214A 6 ( ± 2) x 10-5 -5.6 ± 0.2 
btnOH-AMP 
V219A 8 ( ± 1) x 10-5 -5.5 ± 0.2 
WT 6 ( ± 2) x 10-6 -7.0 ± 0.3 
W223A 3 ( ± 1) x 10-5 -6.1 ± 0.2 
V214A 3 ( ± 1) x 10-5 -6.1 ± 0.2 
bio-5’-AMP 
V219A 8 ( ± 1) x 10-5 -5.5 ± 0.2 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods. The reported values represent the average of at least two independent 
measurements performed by subjecting samples prepared at multiple loading 
concentrations of the relevant complex and centrifuged at multiple rotor speeds. Each 








Figure 15. (A) Proteolytic time course of BirA variant V219A complexed with bio-
5’-AMP shows decreasing amount of intact protein (35 KDa) as a function of time 
after addition of the protease subtilisin. (B) Kinetic time course of pseudo-first order 
cleavage of 2 µM BirA variant V219A () and 2 µM BirA variant V219A + 20 µM 






Table 5. Pseudo-first Order Rates of Proteolytic Cleavage of ABL Variant Proteins 
 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods. The reported rates represent the average of at least two independent 














Wild Type 0.026 ± 0.003 0.004 ± 0.001 6.5 ± 0.3 
V219A 0.032 ± 0.007 0.013 ± 0.004 2.5 ± 0.4 
V214A 0.018 ± 0.006 0.007 ± 0.002 2.6 ± 0.4 
W223A 0.041 ± 0.010 0.008 ± 0.001 5.1 ± 0.3 
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C. Discussion 
In the biotin regulatory system, allosteric activation occurs through ligand-
linked dimerization of the biotin repressor, BirA. The repressor binds substrates 
biotin and ATP to catalyze synthesis of biotinyl-5’-adenylate or bio-5’-AMP (4). The 
adenylate-bound or activated holo-monomer self-associates and the resulting dimer 
then binds to the biotin operator sequence, bioO, to repress transcription initiation at 
the biotin biosynthetic operon (5, 7). Bio-5’-AMP binding initiates the allosteric 
signal that is propagated through the BirA monomer to enhance dimerization. 
Elucidation of the allosteric mechanism in BirA therefore requires determination of  
the ligand-linked structural and dynamic changes in the monomer that are important 
for promoting dimerization. 
 
Combined structural and equilibrium thermodynamic data suggest the 
importance of folding of the adenylate binding loop for the allosteric response. High-
resolution structures are available for the apoBirA monomer and two dimers in which 
the repressor is complexed with biotin or an analogue of bio-5’-AMP, btnOH-AMP 
(30, 31). While enhancement of dimerization energetics upon biotin binding is in 
effect zero, binding of btnOH-AMP results in an enhancement nearly as large as that 
associated with physiological corepressor binding (29). Comparison of the apoBirA 
monomer with the two ligand-bound dimer structures reveals that three loops, which 
are disordered in the unliganded protein, are ordered and participate directly in the 
intersubunit interface of each ligand-bound structure. However, although the two 
dimers share this structural similarity, a major difference is localized to the adenylate 
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binding loop. While in the biotin (weak effector)-bound structure the ABL remains 
disordered, in the btnOH.AMP (strong effector)-bound structure it is folded. Close 
inspection of this loop in the BirA-btnOH-AMP structure reveals that it is folded over 
the adenine ring with side chains of residues V214, V219, and W223 forming a 
hydrophobic cluster (31). While these three residues do not directly interact with the 
adenylate, formation of the core may be important for allosteric activation. Single 
amino acid substitutions of hydrophobic cluster residues were made to assess 
contributions of the core to the functional properties of BirA. 
 
Biotin binding measurements indicate that all ABL variants bind the substrate 
with thermodynamics identical to those measured for the wild type repressor. 
Therefore, biotin binding is independent of perturbations in the adenylate binding 
loop. These results contrast with previous studies of mutations in the biotin binding 
loop, which result in defects in both biotin and adenylate binding. The structure of the 
biotin-bound dimer indicates that while the BBL is folded over the biotin molecule, 
the ABL is not folded. However, in the adenylate-bound dimer both loops are folded 
with the ABL arranged around the adenylate moiety. These structural results support 
the known catalytic mechanism of BirA in which an ordered mechanism operates 
with biotin binding first followed by ATP. Biotin binding to apo-BirA induces 
folding of the BBL, which creates the ATP binding site. In the absence of biotin no 
ATP binding site exists. Taken together these data explain the insensitivity of biotin 
binding to mutations in the adenylate binding loop. 
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Since the ABL is ordered around the adenylate moiety in the BirA:btnOH-
AMP structure the consequences for adenylate binding of altering loop residues were 
investigated. Measurements of both bio-5’-AMP and btnOH-AMP binding were 
performed because, while the former is the physiological effector, structural data are 
available for BirA bound to the latter. Binding measurements for all ABL variants 
indicate the importance of the hydrophobic core residues for adenylate binding. 
Results indicate that both adenylate ligands bind to each variant with affinities 
significantly lower than they do to the wild type repressor. The energetic penalties 
(∆∆Go) for binding btnOH-AMP ranged from +1.5 to +2 kcal/mole and those 
associated with bio-5’-AMP ranged from +1 to +3 kcal/mole. In addition, partitioning 
of the energetic penalty between enthalpy (∆∆Ho) and entropy (T∆∆So) differed for 
the mutants. While for the W223A it was centered in the binding enthalpy, for the 
V214A and V219A variants the energetic penalty was solely in the entropic 
component of binding. Finally, the effects on binding were consistently larger for the 
physiological effector than for the analogue. This suggests that while the analogue is 
a reasonable mimic of bio-5’-AMP, there are differences in the structural details of 
the repressor’s interaction with the two ligands. In conclusion, the adenylate binding 
results indicate that integrity of the cluster is required for tight binding of BirA to bio-
5’-AMP. 
 
Results of sedimentation equilibrium measurements indicate that mutations in 
the hydrophobic cluster result in defective dimerization. In their adenylate-bound 
complexes the three variants exhibit less favorable dimerization energetics as 
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compared to the wild type repressor. The defects in dimerization can be considered in 
terms of the effects of the mutations on the coupling free energy associated with 
adenylate binding. This coupling free energy, ∆GC, is defined as the “extra” favorable 
Gibbs free energy of dimerization that results from binding of the adenylate to 
apoBirA. As indicated previously, the magnitudes of ∆GC for bio-5’-AMP and 
btnOH-AMP binding to wild type BirA are -4 and -3 kcal/mole, respectively. 
Assuming that dimerization of the apo-form of each ABL variant is identical to that 
measured for wild type BirA, the coupling free energy can be calculated for each 
variant. The assumption is justified by the fact that no residues that are directly 
involved in the monomer-monomer interface are perturbed in any of the ABL 
variants. Results of the calculation, which are shown in Figure 16, indicate losses in 
coupling free energy of +0.3 to +0.6 kcal/mole for the analogue and +0.8 to +1.4 
kcal/mole for the physiological effector, bio-5’-AMP. Thus, although mutations in the 
hydrophobic cluster do not directly alter the dimerization interface, disruption of the 
cluster distal to this interface perturbs the allosteric response associated with 
adenylate binding. 
 
Measurements of the heat capacity changes associated with ligand binding and 
the kinetics of subtilisin-mediated proteolysis are consistent with the conclusion that 
mutations in the hydrophobic cluster compromise ligand-linked folding of the ABL. 
The negative heat capacity changes associated with btnOH-AMP binding to all three 
mutants and bio-5’-AMP binding to V214A and V219A are smaller in magnitude 
than those measured for binding of wild type repressor to the two ligands (109-111). 
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These results are consistent with the burial of less hydrophobic surface area in 
binding of the mutants to the two ligands. Bio-5-AMP binding to the W223A mutant 
exhibits a nonlinear dependence of binding enthalpy on temperature. Although this 
phenomenology has been observed in other systems, the explanation for the 
observation in this instance is beyond the scope of this work (112-115). Partial 
proteolysis with subtilisin provides a low-resolution measure of the ligand-induced 
folding of the ABL with bio-5’-AMP binding to wild type BirA resulting in a 6.5-fold 
decrease in the pseudo-first order cleavage rate. By contrast, the bio-5’-AMP-linked 
decreases in proteolysis rates measured for the ABL variants ranged from 2.5 to 5.1 
fold.  This reduced level of protection observed when the hydrophobic core is altered 
is consistent with disruption of ligand-linked folding. These results combined with 
ITC measurements of ligand binding and the dimerization measurements support the 
conclusion that formation of the hydrophobic cluster is integral to adenylate-induced 
folding of the ABL and that this folding is critical for the allosteric response in BirA. 
 
While formation of the ABL hydrophobic cluster is clearly important for the 
allosteric response it is likely that additional structural and dynamic changes in BirA 
are integral to allosteric activation. Although residues 212-223 undergo the disorder-
to-order transition upon adenylate binding, ABL residues other than the hydrophobic 
cluster do not appear to function in the allosteric response. Site-directed mutagenesis 
has been employed to change residues R213, E216, E228 to alanine and none of the 
purified proteins are altered in ligand-linked dimerization (S. Naganathan, 






Figure 16. Coupling free energies, ∆GoC, for linkage of btnOH-AMP or bio-5’-AMP 
binding to WT BirA and each ABL variant were calculated from the difference 
between the free energy of apoBirA self-association and the free energy of 
dimerization of the ligand bound species measured for each of the proteins in the 










AMP-bound repressor reveals that the majority of the charged or polar side chains of 
ABL residues are projected toward solvent. Comparison of the biotin-bound and 
btnOH-AMP-bound dimers reveals several structural differences outside of the ABL 
that may be coupled to adenylate-linked folding of the loop, and thus the allosteric 
response.  For example, in the adenylate-bound structure the dimer interface is larger 
and extends to the C-terminal domains of the two subunits. Comparison of the 
structures of the biotin-bound and adenylate-bound monomers indicates a difference 
in the relative orientations of the C-terminal and central domains, a difference that 
may be linked to adenylate-induced folding of the ABL. Additionally, in the btnOH-
AMP-bound repressor monomer the N-terminal DNA binding domain is rotated 
closer to the central catalytic domain than it is in the biotin-bound protein. This 
difference may also be linked to ABL folding.  Currently hydrogen-deuterium 
exchange coupled to mass spectrometric analysis is being employed to further 
investigate these corepressor-linked structural changes in the repressor monomer. 
 
 Comparison of biotin protein ligases (BPLs) from different species highlights 
the importance of the adenylate binding loop for bio-5’-AMP-linked dimerization 
associated with the transcription repression function. Biotin protein ligases all 
catalyze the same reaction and their sequences are highly conserved across evolution. 
However, sequence comparison of bacterial BPLs, including those from eubacteria 
and archaebacteria, reveals that only a subset are both enzymes and transcriptional 
repressors (116). For example, Pyrococcus horikoshii encodes a monofunctional 
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ligase, which does not contain an N-terminal DNA binding domain and therefore 
does not bind to DNA. High-resolution structures of this ligase reveal significant 
structural homology between it and the C-terminal and central domains of BirA 
(117). Nonetheless, two striking differences are observed. First, although the PhBPL 
is dimeric, the interface is formed by completely different segments of the protein 
than those utilized by BirA for dimerization. Second, and more relevant to this study, 
the adenylate binding loop is significantly truncated in the PhBPL relative to EcBirA. 
Highly divergent bacteria encode bifunctional ligases, and the bifunctionality is, thus, 
considered an ancient feature. As such, organisms such as Pyrococcus horikoshii are 
thought to have lost the DNA binding function. The lack of the adenylate binding 
loop suggests that it too is dispensable because it is not required for the ligand-linked 
dimerization associated with repression of transcription initiation. 
 
 The role of protein dynamics in transmitting allosteric signals in proteins is 
well documented. One view focuses on the coupling of changes in flexibility, as 
determined primarily by NMR dynamics measurements, to the allosteric mechanism 
(118). For example in the transcription factor Catabolite Repressor Protein changes in 
dynamics, both picosecond-nanosecond and microsecond-millisecond, are correlated 
with the negative cooperativity associated with cAMP binding to the protein (119). 
Another view of Freire and colleagues is that low stability regions of a protein play a 
central role in allosteric responses. In the biotin repressor ligand-induced folding of 
such a low stability region appears to nucleate the allosteric response. The mechanism 
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by which this initial response percolates through the remainder of the protein remains 






















III.  A Model for the Biotin Repressor: Biotin Operator Complex   
Investigating the role of flexible loops in the structural mechanism of 
the protein:DNA interaction. 
 
A. Introduction 
Allosteric control operates in a variety of cellular processes including 
transcription regulation. In order to maintain cell homeostasis and viability one way 
that organisms respond to changes in metabolite levels is by controlling the level of 
transcription initiation of specific genes by allosterically regulated transcription 
factors. Allosteric regulation of transcription factors involves binding of an allosteric 
effector, with an accompanying change in conformation to influence the affinity of 
the transcription factor for a specific site on DNA. This chapter discusses the 
structural model of the complex formed between the transcription factor, BirA and its 
target DNA site, bioO constructed by Dr. Z.A.Wood†. It specifically addresses the 
structural mechanism by which an allosteric effector of a site-specific DNA binding 
protein alters its affinity for DNA. 
 
Transcription initiation is regulated by the action of two classes of 
transcription factors, activators and repressors. While, activators enhance 
transcription initiation, repressors inhibit this process. An activator binds at a 
promoter that is near or overlapping an operator sequence. This leads to stabilization 
of the polymerase-DNA interaction and/or promotes conversion of the transcription 
initiation complex from the closed to open complex required for transcription 
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initiation. By contrast, repressors bind to operator sequences and partially block the 
polymerase binding site, preventing transcription initiation (Figure 17). Transcription 
factors typically have an effector binding domain and a DNA binding domain. The 
effector binding domain often also participates in oligomerization. The DNA binding 
domain of the transcription factor contains the DNA-recognition elements required 
for specific protein:DNA binding. Characteristic DNA binding motifs include leucine 
zippers, zinc fingers and helix-turn-helix motifs. The helix-turn-helix (HTH) DNA 
binding motif is most common (120, 121). It consists of two α helices packed against 
each other and linked by a four-residue turn or loop. One of these two helices is the 
recognition helix that binds in the major groove of DNA providing specificity at a 
transcription control sequence. The HTH motif typically consists of additional helices 
that stack against the first two to provide stability. Some HTH motifs are linked to a 
wing (w-HTH), that is formed by a two-stranded β sheet and a turn that extends to the 
minor groove to increase protein:DNA contacts (Figure 18). Transcription factors 
function in DNA binding as monomers (122) or oligomers (15). Many function as 
homodimers that bind to palindromic DNA sites (120).  Oligomerization provides 
multiple DNA-recognition elements in the protein to form a more stable protein: 
DNA interaction.       
 
There are several mechanisms by which the functional properties of a 
transcription factor are allosterically controlled by effector binding to influence the 
protein’s affinity for site specific DNA binding. For the purpose of simplicity, the 
discussion here focuses only on the repressor class of transcription factors. Allosteric  
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Figure 17. Regulation of Transcription Initiation 
Activators bind at the promoter to enhance transcription initiation by stabilizing the 
RNA Polymerase-DNA interaction (top). Repressors bind the operator sequence 
partially blocking the binding site for RNA polymerase, hence preventing 









Figure 18. The winged Helix-Turn-Helix motif.  
A model of the three dimensional structure of the w-HTH of the transcription factor, 
elk-1 complexed with DNA determined by X-ray crystallography (123). The 
recognition helix (green) contacts the major groove of the DNA and the wing 
(yellow) extends into the minor groove of the DNA. This model was generated using 






effectors that bind repressors are classified as inducers and corepressors. While 
inducer binding to a repressor destabilizes its interaction with DNA, corepressor 
binding increases the affinity of a repressor for DNA. Based on the influence of 
effector binding on their mechanistic properties, allosteric transcription repressors can 
be classified into two categories. In repressors that exist as preformed oligomers, 
effector binding alters the affinity for DNA by altering the conformation of the DNA 
recognition elements in the repressor. Some examples of this class are lactose 
repressor (LacR), tryptophan repressor (TrpR), purine repressor (PurR) and nickel 
repressor (NikR). In another class of transcriptional repressors, effector binding 
affects the self-assembly properties of the repressor, and the change in oligomeric 
state alters the affinity for DNA. The diphtheria toxin repressor (DtxR), luecine 
responsive element (LrpA) and the biotin repressor (BirA) belong to this class of 
repressors.  
 
Allosteric effector binding elicits a change in stability of a protein:DNA 
complex by structurally altering the surface of the protein that interacts with DNA. In 
some proteins the effector binding domain is distal to the protein:DNA interface. In 
these cases the response accompanying effector binding takes place from a distance to 
affect the stability of the protein:DNA complex. Most often this effect is achieved by 
altering the conformation of the DNA-recognition elements of the DNA binding 
motifs to influence site-specific DNA binding.  In other proteins, binding of the 
allosteric effector creates a new structural unit composed of the effector and effector 
binding domain that directly participates in the protein:DNA interface. As a 
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consequence, the interface extends beyond the characteristic DNA binding motifs, 
hence increasing the stability of the protein:DNA complex. An example of the former 
mechanism of effector action is the lactose repressor, LacR, which functions in DNA 
binding as a homotetramer. It is formed as a dimer of dimers, in which each dimer 
binds to an operator site. Structural and biochemical data indicate that effector, 
allolactose, binding to the LacR core domain that is distant from the DNA binding 
domain, results in a small hinge movement in the NH2 subdomain of the core domain 
(124). This displaces the hinge helices of the N-terminal domain, thereby 
destabilizing the repressor-DNA interaction (Figure 19). By contrast, in the 
tryptophan repressor, TrpR, the binding site for tryptophan is located at the 
repressor:operator interface in the absence and presence of effector (Figure 20) (66). 
Binding of the effector, tryptophan, serves as a switch between non-specific to 
specific protein:DNA recognition. Based on structural and biochemical analyses, 
different mechanisms have been proposed for the TrpR system (62, 125, 126). One 
model suggests that binding of L-Trp to the protein dimer acts like a wedge between 
the core domain and the DNA binding domain. Another proposes that tryptophan 
binding induces folding of portions of the helix-turn-helix domain of TrpR. In both 
models tryptophan directly participates in the protein:DNA interface and its binding 
results in positioning the recognition helix of each monomer in the proper geometry 
for tight operator binding. The nickel repressor, NikR, is another example in which 
effector binding creates a new structural unit composed of the effector and effector 
binding domains that interacts with DNA. NikR is a homotetramer to which binding 





Figure 19. A model of the three dimensional structure of the LacR dimer determined 
by X-ray crystallography (127). The hinge helix (red) in each monomer, undergoes 
movement to destabilize the protein:DNA interaction formed via the N-Terminal 
Domains. This model was generated using MolMol (28) with the Protein Data Bank 









Figure 20. A model of the three dimensional structure of the holoTrpR 
homodimer:Operator complex determined by X-ray crystallography (127). The 
recognition helix of the HTH domain contacts the major groove of DNA. L-trp 
(yellow) is located at the protein:DNA interface. This model was generated using 





structure of the NikR-operator complex indicates specific and non-specific contacts.  
The ribbon-helix-helix (RHH) domain and repressor:operator interface as shown in 
Figure 21.  These three systems illustrate that at a structural level the stability of the 
protein:DNA complex is affected by binding an allosteric effector  that alters the 
features of the interface formed between the protein and DNA. This occurs through 
two general mechanisms: one involves action at a distance and the second involves a 
direct role for the effector and the effector binding domain in the protein:DNA 
interface.  
 
The biotin repressor, BirA, is an allosteric transcription factor that binds at the 
biotin operon to control biotin biosynthesis (3). The apoBirA monomer binds biotin 
and ATP to synthesize its physiological corepressor, bio-5’-AMP (4). Corepressor 
binding induces dimerization of holoBirA (BirA:bio-5’-AMP) and facilitates its DNA 
binding. As revealed by the x-ray crystallographically determined structure of 
apoBirA, the protein is organized into three domains: a C-terminal domain, a central 
catalytic domain containing the effector binding site and four partially disordered 
loops, and an N-terminal DNA binding domain composed of a winged helix-turn-
helix motif (18). Thermodynamic analyses and comparison of the structures of 
apoBirA, the biotin-bound and adenylate-bound dimers, has enabled an understanding 
of this mechanism of allosteric activation in BirA (18, 27, 29-31). Figure 22 provides 
a schematic representation of the mechanism. Allosteric effector binding induces 
BirA dimerization. Three of the four partially disordered loops in the apoBirA 
structure are ordered in the biotin-bound dimer structure and participate in the 
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dimerization interface. One of these loops is the biotin binding loop (BBL; residues 
110-128), which folds over the biotin moiety. Adenylate binding induces folding of 
the fourth loop, the adenylate binding loop (ABL; residues 212-234). This disorder-
to-order transition that occurs concomitant with adenylate binding nucleates the 
allosteric response in BirA (128). 
 
The BirA homodimer binds to a 40 base-pair, inverted palindromic sequence 
of the biotin operator (bioO) to repress transcription initiation at the two divergent 
overlapping promoters, Pa and Pb of the biotin operon (6). As revealed by solution 
studies, the N-terminal DNA binding domain of each monomer of the dimer interacts 
with the two 12 base-pair termini of the 40 base-pair biotin operator sequence. 
Comparison of the biotin-bound and adenylate- bound dimer structures reveals as 
much as a 19º rotation of the N-terminal DNA binding domain relative to the central 
domain, thereby creating a change in orientation of the winged helix-turn-helix motif. 
This may facilitate a specific and stable protein:DNA interaction.  
 
Extensive biochemical studies have been performed to identify regions on 
BirA and bioO that participate in formation of the repression complex (35, 129). 
Hydroxyl radical footprinting performed on the ligand-bound repressor dimer in the 
presence and absence of bioO revealed decreased reactivity/increased protection 
to/from hydroxyl radical cleavage of the protein backbone when complexed with 
DNA. Increased protection is observed in all domains of the protein structure, with 







Figure 21. A model of the three dimensional structure of the NikR-operator complex 
determined by X-ray crystallography (72). The bound nickel ions are shown in blue. 
The Metal Binding Domain (MBD) Loops are indicated in black and point toward the 
phosphate backbone of the DNA. This model was generated using MolMol (28) with 










Figure 22. Allosteric Activation of the Biotin Repressor 
Ligand binding is positively coupled to repressor dimerization. The 
thermodynamically stable dimer subsequently binds site-specifically to the biotin 
operator sequence, bioO. ApoBirA refers to the unliganded protein and holoBirA is 
the bio-5’-AMP-bound species. Kb, Kdim, and KbioO refer to the equilibrium constants 







of the central domain. The recognition helix and wing of the w-HTH motif of the N-
terminal domain of BirA are protected, consistent with their binding in the major and 
minor grooves of bioO, respectively. Regions of the central domain that are protected 
include residues 65-170 and 187-221. These correspond to portions of the amino-
terminal segment of the central domain, two β-strands, loop 194-199 involved in the 
dimer interface and the two effector binding loops, BBL and ABL. A similar 
approach was employed to probe the surface of bioO that participates in the 
protein:DNA interaction (129). This involved the use of chemical and biochemical 
tools that can detect the accessibility of the backbone and nucleotide bases of the 
DNA in the presence and absence of the holoBirA dimer. These probes include 
hydroxyl radical footprinting, dimethyl sulfate (DMS) protection and DNase I 
sensitivity and their combined results are shown in Figure 23A. The DNase I cleavage 
data indicate increased sensitivity in the central region of the 40 base-pair sequence 
and two specific positions of hypersensitivity at positions -10 and +10, at the termini 
of the inverted palindromic sequence, when bound by the repressor dimer. Hydroxyl 
radical footprinting allowed comparison of free bioO and holoBirA dimer bound bioO 
and revealed four regions of protection from hydroxyl radical cleavage upon dimer 
binding. The dimethyl sulfate protection data provide very specific detail regarding 
repressor contacts with the biotin operator. DMS reacts with N7 of guanine 
nucleotides and N3 of adenine nucleotides, which are accessible from the major and 
minor grooves, respectively. Probing DMS modification of the operator sequence in 
the absence and presence of the repressor dimer allows isolation of specific sites of 
contact between the winged helix-turn-helix of the repressor with DNA. These 
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biochemical data provide a map of the surface of bioO that contacts BirA. It indicates 
that BirA primarily interacts with DNA using the w-HTH motif of each monomer to 
bind to the termini of the biotin operator sequence, and suggests the participation of 
the central domain at the protein:DNA interface. 
 
A detailed comparison of high resolution structures of apoBirA and ligand-
bound dimers has provided valuable information that were used by our collaborator, 
Dr. Zachary Wood, to build a model of the protein:DNA interface. The biotin 
repressor undergoes significant structural changes as a consequence of ligand-induced 
dimerization. Comparison of the apoBirA and the adenylate-bound dimer structures 
exhibits significant differences in the structural features that correlate with the 
thermodynamic properties of the system (18, 31). The dimer structure reveals large 
decreases in solvent accessible surfaces as compared to apoBirA. These regions 
exhibit less mobility/flexibility as evidenced by their lower B-factors and show 
improved packing in the structure of the adenylate-bound dimer. Improved packing is 
observed at the dimerization interface and extends to large portions of the central and 
C-terminal domains, which is consistent with formation of a more thermodynamically 
stable homodimer. The effector binding loops, BBL and ABL, located in the central 
domain also display improved packing as an outcome of allosteric effector binding. A 
striking observation is the correlation between these regions of increased packing 
with those of the dimer backbone that are protected from hydroxyl radical cleavage 
upon allosteric effector binding. This comparison is shown in Figure 23B.  Although 
the structure of the BirA homodimer:operator complex has not been solved, these 
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correlations provided a basis to systematically build a model of the holoBirA 
dimer:bioO complex using a combination of structural and biochemical data. 
 
The model of the holoBirA dimer:bioO complex was preliminarily built by 
manual docking of the N-terminal DNA binding domains of BirA in the adenylate-
bound dimer structure onto bioO, utilizing the binding relationship between winged 
helix-turn-helix motifs and the DNA backbone (Figure 23C). Based on the DMS 
modification data obtained on the nucleotide accessibility in bioO, the contacts 
between the BirA dimer and bioO are refined. Consequently, interactions between the 
N-terminal domains of the BirA dimer and bioO are off the center axis of the duplex, 
to form the protein:DNA interaction. The Adaptive Poisson-Boltzmann Solver allows 
efficient calculation of electrostatic properties of protein structures. Such calculations 
performed on the adenylate-bound dimer structure reveal multiple exposed charges on 
the surface of BirA. In addition to the concentration of positive charges observed at 
the N-terminal DNA binding domains, is the large span of positive charges located in 
the effector binding loops of the repressor’s central domain as demonstrated in Figure 
23D. Based on this prominent feature, the central catalytic domain was lowered onto 
the DNA backbone in the model in order to accommodate possible electrostatic 
interactions between the positive charges on the protein surface and the negative 
backbone of the DNA. This was made possible by allowing for a minor 
conformational change at the linker region between the N-terminal domain and the 
catalytic domain, which, based on the adenylate-bound dimer structure, is considered 
highly mobile. Lowering the central domain onto the DNA backbone also accounts 
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for the regions of contact at the protein:DNA interface revealed by the hydroxyl 
radical footprinting data obtained on the repressor and bioO.  Overall, the model 
displays a new structural element composed of the effector and effector binding 
domain at the protein:DNA interface (Figure 24).  
 
Based on the holoBirA dimer:bioO model, it is anticipated that the effector 
binding loops and the DNA backbone interact via salt bridges. These contacts 
predominate between positively charged residues, Arg116 and Lys122 of the BBL 
and Arg212 and Arg213 of the ABL and the DNA backbone (Figure 25). It is 
noteworthy that these positively charged residues are located in the sequences 65-170 
and 187-221 that were protected from hydroxyl radical cleavage in the ternary 
complex. This model of the holoBirA dimer:bioO complex suggests another example 
of an allosteric transcription repressor in which the effector binding region forms part 
of an extended interface between the repressor dimer and DNA to form a stable 
repression complex. 
 
In this chapter a site-directed mutagenesis approach is employed to test the 
proposed model. Single, double and quadruple amino acid replacements of residues 
R116, K122, R212, and R213 to alanine were constructed. The DNA binding 
properties of these variant repressor proteins were evaluated using the DNase I 
footprinting technique. This approach enables assessment of the effect of disrupting 
putative electrostatic contacts between the effector binding loops of the repressor 
dimer and bioO phosphate backbone on the total assembly properties of the ternary 
 90 
complex. Overall, the results of this study reveal no significant differences in the total 
assembly energetics of the repression complex, even upon total abolition of all four 
positively charged residues. These results indicate that the effector binding loops do 
not contribute significantly to stabilizing the transcription repression complex through 





















The model presented in this chapter of the holoBirA dimer:bioO complex was 
entirely constructed and proposed by Dr. Zachary A. Wood, an x-ray crystallography 
collaborator at University of Georgia. Figures 23-25 used to describe the model were 


























Figure 23. Construction of the hypothetical model of the holoBirA dimer:bioO 
complex. (a.) Solution structural probing of bioO bound by the repressor dimer. 
Regions of protection of bioO against hydroxyl radical agent (red), DNase I (pink) 
and dimethyl sulfate (blue). (b.) Comparison of packing interactions determined from 
structural data (left) and protection from hydroxyl radical cleavage data (right). Both 
images are generated by comparing apo and corepressor bound dimer. Colored 
regions represent increased packing/protection upon binding the corepressor. Images 
are bottom views of the dimer. (c.) Manual docking of the winged-helix-turn-helix 
motif of BirA onto the DNA backbone. (d.) APBS calculated electrostatic surface of 
BirA. Depicted are the positive (blue), negative (red) and neutral (white) charges on 
the surface of BirA. The DNA binding domain (bold) and effector binding domain 
(dotted) are highlighted on the bottom (left) and side (right) views of the repressor 
dimer.  














Figure 24. A hypothetical structural model of the holoBirA dimer:bioO complex. 
The N-terminal domains are bound at the termini of the DNA and off the center of 
axis of the DNA duplex. The central region of the repressor dimer is lowered. This 







     
 
 
Figure 25. Effector binding loops extend towards the bioO backbone 
Positively charged residues of the effector binding loops of BirA extend toward the 
phosphate backbone of bioO. Residues R212 and R213 of the ABL (magenta) and 













A model for the holoBirA dimer:bioO complex was built using structural and 
biochemical data and described in the Introduction to this chapter. The model 
proposes that the structural mechanism of corepressor function involves creating a 
new structural module for interaction between the protein and DNA via the effector 
binding loops of the central domain. It is postulated that the positively charged 
residues in the effector binding loops interact directly with the DNA backbone by 
forming salt bridges. The focus of this chapter is to test the effect of disrupting these 
putative electrostatic interactions at the protein:DNA interface on ternary complex 
assembly. The BirA variant proteins R116A and K122A of the BBL, and R212A and 
R213A of the ABL, the double mutants: R116A/K122A, R212A/R213A and the quadruple 
mutant repressor, R116A/K122A/R212A/R213A were constructed. These variant proteins 
were subjected to quantitative DNase I footprinting measurements to evaluate their 
effects on the energetics of total assembly of the repression complex. 
 
1. Bio-5’-AMP Binding to BirA Variant Proteins 
Corepressor, bio-5’-AMP binding to BirA induces its dimerization and 
subsequent DNA binding. Thus in this system, ligand binding is positively coupled to 
the assembly of the repression complex. The DNase I footprinting technique was 
utilized to determine the DNA binding and total repression complex assembly 
properties of the BirA variants. In order to design the measurements using saturating 
concentration of corepressor, the bio-5’-AMP binding affinities of the variants 
proteins were first determined by equilibrium titration methods using isothermal 
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titration calorimetry and steady-state fluorescence measurements as described in the 
Materials and Methods section. All experiments were performed at sufficiently low 
protein concentration to eliminate any contribution of coupled dimerization to the 
binding process.  Representative data are shown in Figure 26A-C. The 
thermodynamics of bio-5’-AMP binding to the variant proteins are shown in Table 6.  
BirA variant K122A and all variant proteins containing the Arg116Ala mutation 
exhibited significantly weaker affinities for the ligand.  
 
2. Dimerization Properties of bio-5’-AMP bound Repressor Variants  
Assembly of the repression complex occurs by coupled dimerization and 
DNA binding. Solution studies have shown that repressor dimerization precedes 
DNA binding in formation of the repression complex (16). Therefore, the total 
assembly energetics of the repression complex represents the sum of the energetics of 
dimerization and that of DNA binding by the dimer. In order to deconvolute these 
two processes and determine defects in DNA binding alone, it is critical to measure 
the dimerization properties of the repressor variants. The dimerization energetics 
were measured for the single mutant BirA proteins under standard buffer conditions 
by sedimentation equilibrium. Figure 27 shows results of data obtained for the BirA-
bio-5’-AMP complex. The results indicated moderate to no significant differences in 
the dimerization properties of these variants as compared to the wild-type repressor 
(Table 7). BirA variants K122A and R212A exhibit moderate defects in dimerization 
energetics of +0.5 and +0.9 kcal/mol, respectively.     
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Figure 26. Bio-5’-AMP Binding to BirA Variant Proteins 
 (A) Direct equilibrium titration of biotin binding R213A. (B) Displacement titration 
of bio-5’-AMP binding R213A saturated with biotin. (C) Equilibrium binding 
titration obtained by steady-state fluorescence measurement of bio-5’-AMP binding 
R116A/K122A/R212A/R213A. Data were fit as described in the Materials and Methods 
section. All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 
7.50 ± 0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials 
















Table 6. Thermodynamics of Bio-5’-AMP Binding to BirA Variant Proteins: 
 
BirA Variant Kb (M)
a ∆Go  (kcal/mol)b 
WT 3.9 ( ± 1.9) x 10-11 -13.9 ± 0.4 
R116A 2.2 ( ± 0.3) x 10-7 -8.9 ± 0.1 
K122A 1.8 ( ± 0.4) x 10-8 -9.0 ± 0.2 
R212A 3.3 ( ± 1.0) x 10-11 -14.0 ± 0.2 
R213A 2.8 ( ± 1.5) x 10-11 -14.0 ± 0.3 
R116A/K122A 9.5 ( ± 1.3 ) x 10-7 -8.0 ± 0.3 
R212A/R213A 6.5 ( ± 1.1) x 10-10 -12.3 ± 0.2 
Quadruple 4.7 ( ± 1.0 ) x 10-7 -8.5 ± 0.2 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in the Materials and 
Methods section. The reported values represent the average of at least two 
independent titrations with standard deviation. a. Values of Kb are the best-fit values 
obtained from nonlinear least squares analysis of the titration data to a simple one-site 
binding model using Origin or GraphPad Prism 4. b. The values of the Gibbs free 
energy, ∆Go, were calculated using the expression ∆Go=RTlnKb. Equilibrium binding 
measurements by steady-state fluorescence were performed for bio-5’-AMP binding 
to the BirA R116A variants, both double mutants, and the quadruple. All other 
measurements were made using ITC employing the displacement titration method as 
discussed in Materials and Methods. Bio-5’-AMP binding to BirA variant K122A 




Figure 27. Absorbance versus radial position for 45 µM R212A.bio-5’-AMP at 
22,000 (◊), 26,000 (♦) and 30,000 (o) rpm obtained in standard buffer at 20 ˚C. The 
best-fit curves were generated from global analysis using a monomer-dimer model of 
six data sets acquired at multiple loading concentrations and spun at three speeds. The 




Table 7. Dimerization Properties of BirA Variant- bio-5’-AMP Complexes 




WT 6 ( ± 2) x 10-6 -7.0 ± 0.3 
R116A 5 ( ± 2) x 10-6 -7.1 ± 0.3 
K122A 2.1 ( ± 0.6) x 10-5 -6.2 ± 0.2 
R212A 1.5 ( ± 0.6) x 10-5 - 6.4 ± 0.3 
R213A 5 ( ± 2) x 10-6 -6.9 ± 0.3 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods.  The reported values represent the average of at least two independent 
sedimentation equilibrium measurements performed by subjecting samples prepared 
at multiple loading concentrations of the variant-bio-5’-AMP complex to 
centrifugation at multiple rotor speeds. Reported errors represent 95% confidence 
intervals. The resulting data sets were subjected to global analysis using a monomer-







3. Binding of BirA Variant Proteins to bioO 
DNase I footprints of holoBirA wild-type and variant proteins binding to bioO 
were performed under standard buffer conditions (10 mM Tris-HCl (pH 7.50 ± 0.02 
at 20.0 ± 0.1 oC), 200 mM KCl, 2.5 mM MgCl2) and were all qualitatively similar. A 
representative footprint of BirA variant R213A binding to bioO is shown in Figure 
28. Binding isotherms obtained from quantification of the footprints reflect both 
dimerization and DNA binding processes. The data were subject to non-linear least 











=         ………………...(1) 
The expression relates the fractional occupancy,Y , to the holoBirA concentration. 
KDIM is the equilibrium association constant for repressor dimerization and KbioO is the 
equilibrium association constant for dimer binding to bioO. This model is used in 
non-linear least-squares analysis of the data to obtain the KbioO. The KDIM was fixed at 
the value resolved from sedimentation equilibrium measurements. The results of free 
energies of the variant repressor dimers binding to bioO are shown in Table 8. The 
free energy of total repression complex assembly, ∆GºTOT, can be calculated using the 
equations:  ∆GºTOT= -RTln(KbioOKDIM) or ∆GºTOT = ∆GºDIM + ∆GºbioO.  
 











=     ……………...(2) 
is used to fit the data to obtain KTOT, the equilibrium association constant for total 
assembly of the holoBirA dimer:bioO complex, which is the product of KDIM and 
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KbioO. The free energy of total repression complex assembly, ∆GºTOT, can be 
calculated using the equation ∆GºTOT= -RTlnKTOT.  
 
The binding isotherms and best fit curves of each variant repressor protein 
binding to bioO compared with that of the wild-type repressor are displayed in Figure 
29. Resolved parameters shown in Table 8 indicate that the total free energies of 
assembly of the repression complex for the variant repressor proteins are not 
significantly different from that of wild-type BirA. As compared to the ∆GºTOT for 
wild-type holoBirA dimer:bioO assembly which is -19.7 ± 0.4 kcal/mol, the variant 
proteins exhibit only about  ± 1 kcal/mol differences.  Additionally, the total 
assembly energetics resolved using models (1) and (2) for the single mutation 
repressor variants were in agreement with each other.  
 
C. Discussion 
Transcription regulation involves binding of transcription factors to specific 
sites on DNA. The affinity of protein-DNA interactions can be modulated by binding 
of an allosteric effector to the transcription factor. Effector binding is accompanied by 
conformational changes that alter the structural features of the protein’s surface that 
interacts with DNA. The aim of this chapter was to investigate the role of the effector 
in influencing the structural features of the protein:DNA interface of the complex 






Figure 28. DNase I Footprinting of BirA variant R213A-bio-5’-AMP with bioO 
The footprint was obtained in buffer containing 10 mM Tris-HCl (pH 7.50 ± 0.02 at 
20.0  ± 0.1 °C), 200 mM KCl, 2.5 mM MgCl2, 1 mM CaCl2, 2 µg/mL sonicated calf 




Figure 29. DNA binding isotherm of holoBirA Variant Repressors to bioO 
Each panel represents the variant repressor binding to bioO, superimposed with that 
of wild-type BirA. (■) correspond to wild-type and (◊) to BirA variant data obtained 
from quantitation of footprinting gels. The best fit curves are from fitting data to 
equation (2) are represented (grey) for wild-type and (black) variant repressor. R3K 





Table 8. Energetics for Total Assembly of the Repression Complex  
BirA Variant ∆GobioO
  (kcal/mol)a ∆GoTOT
  (kcal/mol)b 
WT -12.7 ± 0.3 -19.7 ± 0.4 
R116A -13.1 ± 0.2 -20.0 ± 0.1 
K122A -14.0 ± 0.2 -20.2 ± 0.2 
R212A -14.5 ± 0.2 -20.9 ± 0.2 
R213A -12.9 ± 0.2 -19.8 ± 0.1 
R116A/K122A n.d. -19.9 ± 0.2 
R212A/R213A n.d. -19.6 ± 0.2 
Quadruple n.d. -19.1 ± 0.1 
    
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods.  
(a.) Footprinting data were fit by fixing the KDIM obtained from sedimentation 
equilibrium measurements to equation (1) to determine KbioO. (b.) Footprinting data 
were fit to obtain KTOT using equation (2). All reported values represent the average 




Detailed solution studies and structural data obtained on the biotin repressor 
have enabled an understanding of the mechanism of allosteric activation in BirA. This 
mechanism involves binding of the corepressor, bio-5’-AMP, which enhances 
holoBirA dimerization, and subsequent biotin operator binding. Although a structure 
of the repression complex has not yet been solved, chemical and biochemical probing 
combined with structural data have provided insight into the interface formed in 
holoBirA dimer: bioO complex (35, 129). Based on these data, a model for the 
interaction between the dimer and DNA was predicted. Dimethyl sulfate (DMS) 
protection data provided very specific detail regarding repressor contacts with the 
biotin operator. The wHTH motif of BirA is expected to contact the 12 base pair 
termini of the 40 base pair bioO sequence via the recognition helix in the major 
groove and wing extending into the minor groove. This interaction produces a 40 
degree bend in the central region of the DNA, distorting it toward the dimer in the 
repression complex, as evidenced from circular permutation analysis (129). While 
these data provided a preliminary understanding of the protein:DNA interaction, this 
study presents a combination of modeling and experimental measurements to dissect 
the participation of the effector binding region at the protein:DNA interface. 
 
Combining the data summarized in the previous paragraph with calculations 
of the surface electrostatics of BirA obtained from structural data, our x-ray 
crystallography collaborator, Dr. Zachary A. Wood constructed a model for the 
dimer:DNA complex. The model was used to postulate the structural mechanism by 
which allosteric effector-induced alteration in BirA affects its surface of interaction 
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with bioO. It suggested direct contact between the effector binding region of BirA 
and central region of bioO. Electrostatic interactions are predicted between the 
effector binding loops located in the central domains of the repressor dimer and the 
DNA backbone. Direct participation of the loops in DNA binding would raise an 
interesting structural mechanism in the context of allosteric activation in BirA. These 
loops are also involved in allosteric effector binding and in the allosteric activation 
mechanism of BirA. In this study, mutations of positively charged residues that 
should abolish the putative electrostatic interactions were constructed to test the 
predictions of the model. Mutant repressor proteins were subjected to thermodynamic 
characterization of their ligand binding, dimerization and repression complex 
assembly properties. 
 
Since ligand binding is positively coupled to repression complex assembly, 
the bio-5’-AMP binding properties of the BirA variants were determined. 
Measurements indicate that BirA variants R212A and R213A bind the effector with 
affinities identical to that measured for the wild-type repressor. However, bio-5’-
AMP binds to BirA variants K122A and all variants containing the mutation R116A 
with affinities significantly lower than for the wild type repressor. The energetic 
penalties (∆∆Go) for these variants ranged from +4.1 to +5.9 kcal/mol. Inspection of 
the effector-bound dimer structure of BirA indicate that biotin binding is 
accompanied by folding of the BBL, thereby creating the binding site for ATP. 
Folding of the biotin binding loop contributes two hydrogen bonds from the main-
chain atoms of R116 to the ureido ring of biotin and additional packing interactions to 
 109 
create the adenylate binding pocket (31). It is conceivable that disruption of K122 and 
R116 affects folding of the BBL required to make these contacts. 
 
Sedimentation equilibrium measurements were performed to determine 
defects in dimerization properties of the variant proteins. The dimerization energetics 
measured for the single mutation BirA variants indicate that while R116A and R213A 
are unaffected, variants K122A and R212A exhibit defects of +0.6 to +0.8 kcal/mol 
as compared to the wild-type repressor. Structural data indicate that none of these 
residues participate directly at the dimerization interface. Moreover, based on ligand 
binding and dimerization measurements, it is evident that defects in ligand binding do 
not directly correlate with defects in dimerization for these variant repressors.  
   
  DNA binding and repression complex assembly properties of the variant 
repressors were measured by the DNase I footprinting technique. The energetics of 
total assembly of the repression complex was used to test the validity of the structural 
model. Results indicated only a moderate 0.9 kcal/mol loss in total repression 
complex assembly energetics, even with the quadruple mutant. This result is 
contradictory to predictions based on the model that eight putative electrostatic 
interactions (four for each monomer) exist between the effector binding loops of the 
dimer and the bioO backbone. The discrepancies between the predictions from the 
model and experimental results are addressed below. 
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 Assembly of the repression complex occurs by coupled dimerization and 
DNA binding (16). The energetics of bioO binding were measured for the single 
mutation BirA variants. The total free energy of repression complex assembly was 
calculated for these variants from the sum of their dimerization and bioO binding 
energetics. These values agreed well with that obtained from fitting DNase I 
footprinting data to obtain their energetics of total assembly. However, the results 
raised an interesting observation with variants K122A and R212A. Although these 
variants were moderately defective in dimerization, their total assembly energetics 
were unaffected. Defects in dimerization energetics were compensated by the 
energetics of bioO binding. The contributions to the compensatory energetics are 
presently unclear and will require further investigation. 
 
 The electrostatic contributions to protein:DNA interactions have been 
evaluated in several protein:DNA complexes through extensive experimental 
measurements. For example, solution studies performed on the LacR:operator binding 
process has revealed release of 8 cations upon binding of the homotetramer, LacR, to 
its operator sequence. This stoichiometry of ion release is consistent with structural 
data on the repressor:DNA complex, which indicates eight electrostatic interactions 
between the protein and phosphates of the DNA backbone (114, 130, 131). The 
model of the holoBirA dimer:bioO complex predicts eight electrostatic interactions 
between the effector binding loops and the DNA backbone, in addition to those 
formed via the DNA binding motifs of the protein with the DNA backbone. The 
combined electrostatics should be revealed by measuring the salt dependence of DNA 
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binding. However, measurements performed by DNase I footprinting to determine the 
electrostatic contribution to the BirA dimer binding to bioO and to total assembly of 
the dimer-DNA complex, indicated only a modest release of 2.5 ± 0.3 ions (107). 
This surprisingly low apparent stoichiometry of ion release for this process could be a 
consequence of ion uptake by the DNA or by the protein in the coupled process of 
dimerization and DNA binding. The experimentally determined small number of ions 
released does not correlate with the large number of putative electrostatic interactions 
predicted by the model.  
 
The moderate loss in total assembly properties of BirA variants in the effector 
binding loops and the modest number of ions released in the dimer-DNA binding 
process is inconsistent with formation of multiple electrostatic interactions at the 
protein:DNA interface. In view of these discrepancies between the proposed model 
and experimental results, a critical analysis of the construction of the structural model 
revealed several oversights. First, comparison of the hydroxyl radical footprinting 
data obtained on the corepressor-bound dimer and the complete repression complex 
suggested that the dimer:DNA complex assembly involves formation of an extended 
surface of interaction at the protein:DNA interface. This was based on the increased 
protection from cleavage accompanied by formation of the repression complex. In the 
corepressor-bound dimer the BBL and ABL undergo 90% and 50% increased 
protection respectively, from cleavage as compared to apoBirA monomer. However, 
while formation of the repression complex results in a 90% increased protection in 
regions of the N-terminal segment of the central domain, the ABL undergoes only a 
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40% greater protection and the BBL undergoes no significant change. These 
observations highlight that interaction between the dimer and bioO offers only minor 
changes in the accessibility of effector binding loops to hydroxyl radical cleavage. 
Therefore, it is conceivable that while formation of the repression complex could be 
accompanied by increased contacts between the central domains of the dimer and 
DNA backbone, the effector binding loops do not play a critical role in the 
interaction. Formation of the repression complex merely increases the packing 
interactions at the protein:DNA interface and is not supplemented by electrostatic 
contacts as proposed by the model. Moreover, changes in reactivity to hydroxyl 
radical could be a representation of a global change in the protein instead of specific 
conformational rearrangements. It has been suggested that in cAMP receptor protein 
(CRP) binding to DNA, the sensitivity to hydroxyl radical cleavage reflects a 
combination of solvent accessibility, charge and hydrophobicity (132). Therefore, the 
hydroxyl radical cleavage data are not comprehensive in the context of constructing 
this model. Second, the model for the holoBirA dimer:bioO was constructed with the 
omission of a valuable experimental result. Use of the circular permutation analysis 
technique on bioO in the holoBirAdimer-bio complex, indicated that the DNA 
deviated from linearity in the order of 40 degrees toward the dimer. Although this 
assay provided information on a global level rather than identification of a local point, 
extensive mapping of the DNA in the repression complex enabled isolation of three 
loci of bending. These correlate with the three DNase I hypersensitive sites: two at 
the 12 base-pair termini that interact with the wHTH motifs of the repressor dimer, 
and one in the central region of the 40 base-pair bioO sequence. The structural model 
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of the holoBirA dimer:bioO complex was constructed without consideration of the 
bend angle in the central region of the DNA. Collectively, these oversights of 
experimental data could have resulted in an inaccurate representation of the 
protein:DNA complex.     
   
The model of the holoBirA dimer:bioO complex provided a preliminary 
assessment of the structural features of the protein- DNA interface. However, this 
chapter has presented a good example of making too many inferences about 
functional features of a system based on structural modeling. Several attempts have 
been made to crystallize the holoBirA dimer-bioO complex but have proven 
unfruitful. Thus, in absence of an experimentally determined structure, refinement of 
the existing model with the inclusion of the DNA bend angle could provide a more 
accurate representation of the repressor dimer:DNA complex. In recent years, several 
computational approaches have been taken to predict electrostatics, solvation, and 
hydrogen bonding in protein-DNA interactions. Models developed to efficiently 
calculate such factors important in predicting specific and non-specific protein-DNA 
interactions have shown excellent correlation with experimental measurements (133). 
In future work a refined model of the biotin repression complex could be subjected to 
computational and experimental analyses to better dissect the structural mechanism of 




IV. The Roles of Flexible loops in BirA in Alternative 
Protein:Protein Interactions.           
 
A. Introduction  
A protein’s functional properties are regulated in response to cellular 
requirements. One common mode of regulation of protein function is through 
interaction with another protein partner. For example, some enzymes can control gene 
expression in response to the availability of their substrates. These enzymes by 
forming specific protein:protein interaction with transcription factors control their 
ability to regulate transcription initiation (134). In other systems alternate distinct 
functions of a protein are modulated via exchange of one protein partner for another. 
This class of multi-functional proteins contributes to important biological processes 
and an understanding of their mechanisms of regulation requires elucidation of the 
structural, kinetic and thermodynamic rules that govern acquisition of different 
partners.  
 
The structural features by which a single protein forms specific interactions 
with different protein partners to control biological function is not well understood. 
However, one of the best studied is β-catenin which functions in transcriptional 
activation and in cell-cell adhesion (89) As a coactivator of transcription initiation β-
catenin interacts with members of the T-cell factor (Tcf)/ lymphoid enhancer factor 
(LEF) family of transcription factors. Alternatively, β-catenin interacts with cadherins 
in its cell adhesion function. Structural data indicate that the same β-catenin surface is 
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used to form complexes with its two partners, and that the chemistries of the two 
interfaces are very similar (91, 92). In this system the utilization of a single protein 
surface in alternative protein:protein interactions makes the distinct functions 
mutually exclusive. The ability of a single protein to be both promiscuous and 
specific in interaction with two different protein partners is crucial to functional 
switching. In this study we examine the physical-chemical and structural features 
important to formation of alternative protein:protein interactions of a bifunctional 
protein. 
 
The Escherichia coli Biotin Regulatory System provides an example of a 
protein for which binding partner decides functional fate. The central component of 
the system, BirA, the biotin repressor/biotin protein ligase functions as a 
transcriptional repressor and a metabolic enzyme (2, 3) (Figure 30). As an enzyme 
BirA catalyzes biotin linkage to the biotin carboxyl carrier protein (apoBCCP), a 
subunit of the acetyl-CoA carboxylase enzyme (ACC). In this two-step reaction the 
apoBirA monomer first binds to biotin and ATP to catalyze synthesis of the 
intermediate, bio-5’-AMP (4). The resulting bio-5’-AMP bound form of BirA, 
holoBirA, then transfers biotin to the BCCP subunit of ACC, which catalyzes the first 
committed step of fatty acid synthesis. As a transcriptional repressor BirA binds 
specifically to the 40-base pair biotin operator sequence (bioO) to repress 
transcription of the biotin biosynthetic operon (5, 6). The intermediate in biotin 
transfer, bio-5’-AMP, also induces BirA homodimerization, thereby facilitating 
repression complex assembly. Thus the activated monomer, holoBirA, serves as an 
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obligate species in both functions. Moreover, the functional switch between 
metabolism and transcription repression occurs by alternative protein:protein 
interactions in which holoBirA forms a homodimer or a heterodimer with apoBCCP.  
 
Structurally, the functional switch in BirA reflects formation of two mutually 
exclusive protein:protein interfaces. The structure of the BirA homodimer bound to 
effector has been solved by x-ray crystallography (30, 31). The homodimer interface 
is formed through side by side anti-parallel alignment of the β-strand, composed of 
residues 188-196 of each holoBirA monomer’s central domain to form an extended β-
sheet. Additionally, three loops located in the central domain participate at the 
dimerization interface. While the structure of the BirA:apoBCCP complex has not 
been determined, a model has been proposed (97). The model was generated by 
docking a holoBirA monomer from the homodimer structure with the experimentally 
determined structure of apoBCCP87 (135). BCCP87 is the C-terminal fragment of 
BCCP that is functionally identical to intact BCCP in biotin transfer (136). As 
observed in the homodimer structure, the heterodimer interface is formed by aligning 
the same β-strand (residues 188-196) of the holoBirA monomer used in 
homodimerization with a β-strand, composed of residues 122-128, of apoBCCP in a 
parallel orientation. The model is supported by combined structural and mutagenesis 
studies (93). Moreover, the general features of the model were confirmed in an 
experimentally determined structure of the BirA paralog, Pyrococcus horikoshii 
biotin protein ligase, bound to its acceptor protein (137). Based on the experimentally 
determined and modeled structures of the homodimer and heterodimer, respectively  
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Figure 30. A schematic representation of the biotin regulatory system.   
The activated protein, BirA-bio-5’-AMP, switches between functioning as a biotin 






Figure 31. Structural Models of the Homodimer and Heterodimer 
Structural models of the BirA-apoBCCP heterodimer and holoBirA homodimer. The 
activated holoBirA monomer switches between two mutually exclusive 
protein:protein interactions. Models were constructed using the program MolMol (28) 
with Protein Data Bank files 2EWN for the homodimer and 1K67 for the heterodimer 
(hypothetical model) as input. The activated monomer was constructed using one 




(Figure 31), it is evident the two interactions use the same BirA surface for 
dimerization, thus rendering them mutually exclusive. 
 
In vivo and in vitro approaches have been employed to determine the 
mechanism of functional switching of BirA between metabolism and transcription 
repression. ApoBCCP production is controlled by growth rate (138). In rapidly 
dividing cells, apoBCCP concentration increases in response to requirement for fatty 
acids. It has also been shown that the intracellular apoBCCP concentration influences 
transcription repression at the biotin biosynthetic operon. In bacterial cultures in 
which transcription initiation at the biotin operon is repressed, induction of apoBCCP 
synthesis results in derepression (93, 94). A reasonable interpretation of these results 
is that apoBCCP engages holoBirA, thereby depleting the holoBirA pool available for 
homodimerization. Since dimerization is a prerequisite of biotin operator binding, 
derepression occurs.  
   
The biological and structural features of the biotin regulatory system are 
consistent with control of BirA function by competitive and mutually exclusive 
interactions. In theory, the control can occur at either an equilibrium or kinetic level. 
The equilibrium dimerization constant, KD, of holoBirA homodimerization measured 
by sedimentation equilibrium is 6 ± 2 µM (27). Direct measurements of the 
heterodimer binding interaction are prohibited by the chemistry that follows 
association of holoBirA with apoBCCP. However, measurement of the interaction 
could be accomplished by an indirect method. The holoBirA-apoBCCP interaction 
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was monitored through perturbation of holoBirA homodimer occupancy of the biotin 
operator using the inhibition DNase I footprinting technique (96). The inhibition data 
obtained over a range of apoBCCP concentrations revealed an inhibition constant for 
apoBCCP of 2 ± 1 µM. This value agreed well with measurements of partitioning 
between the two interactions by sedimentation velocity (95). Overall, the similar 
equilibrium constants for formation of the homodimer and heterodimer are consistent 
with kinetic rather than thermodynamic control of the functional switch in BirA. 
Moreover, sedimentation velocity measurements employed to investigate the kinetics 
of holoBirA dimerization indicate that the process is characterized by unusually slow 
kinetics (95), thus lending further support to a kinetically controlled switch. 
 
Results of combined structural and biochemical studies indicate that the two 
dimerization processes dictating the functional switch in BirA are energetically 
equivalent yet structurally distinct. The detailed physical basis of formation of these 
two distinct interactions using a single holoBirA surface remains unclear. Although 
they are isoenergetic, preliminary evidence suggests that the detailed chemistries of 
the two interactions are not equivalent. For example, bio-5’-AMP and its non-
hydrolyzable analogs, btnSA (5’-O-[N-(biotinyl) sulfamoyl] adenosine) and btnOH-
AMP (biotinol-adenylate) are structurally similar. Like bio-5’-AMP, binding of these 
analogs to BirA promotes homodimerization, albeit to lesser extents than does the 
physiological effector (29). By contrast, complexes of holoBirA bound to these 
analogs do not interact with apoBCCP. The ability of apoBCCP to discriminate 
between the dimerization surfaces of the different holoBirA monomers suggests 
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distinct dimerization chemistries. Moreover, while homodimerization is characterized 
by large temperature dependence with an enthalpy of + 41 kcal/mol, preliminary 
measurements performed at two temperatures indicate that the enthalpy associated 
with heterodimerization is negligible (107). These results prompt further investigation 
of the detailed structural elements required for the two dimerization interfaces. 
 
Previous studies of BirA mutants that are perturbed in homodimerization have 
revealed two classes of defects, including those that directly disrupt the 
protein:protein interface and those that perturb allosteric activation of dimerization by 
bio-5’-AMP. Single site mutations of residues R118 and R119 located in a flexible 
loop that participates at the dimerization interface are severely defective in 
homodimerization (32). These residues are part of a glycine rich sequence that is 
conserved in all biotin ligases. Moreover, deletion of residue A146 and mutation of 
residue D197 located in two other loops that participate at the dimer interface results 
in dramatic defects in homodimerization (32). Mutations of residues located in a 
flexible loop distal to the dimerization interface have also shown defective 
homodimerization properties and belong to the class of allosteric mutants. In the 
structure of the adenylate-bound BirA residues V219, V214 and W223 form a 
hydrophobic cluster over the adenine ring of the ligand (31). Single site mutations of 
these residues moderately perturb the homodimerization energetics (128). 
Furthermore, formation of the cluster is integral to the disorder-to-order transition of 
the flexible loop involved in allosteric signal transmission. These combined mutants 
 122 
provide tools to investigate the structural requirements for heterodimer formation 
between holoBirA and apoBCCP. 
  
The focus of this study is to investigate the physical-chemical and the 
structural determinants of homo- and hetero-dimerization of BirA. Both the salt and 
temperature dependence of heterodimerization were measured by sedimentation 
equilibrium. Results of these studies indicate modest dependence of the interaction on 
both solution variables. The mutants described above that are defective in 
homodimerization and additional mutants subjected to analysis of homodimerization 
in this work, are examined for their effects on heterodimerization (Figure 32). 
Heterodimerization properties of variant proteins were probed using two techniques. 
In one, the process was assessed by monitoring inhibition of homodimerization of 
wild-type and mutant holoBirA proteins. This inhibition was detected by its effect on 
bioO occupancy. In the second assay, the heterodimerization interaction was 
measured by determining the kinetics of BirA-catalyzed transfer of biotin to 
apoBCCP. The combined results indicate that, consistent with the results of 
homodimerization measurements, the BirA variants exhibit a range of defects in 
heterodimerization. Results of measurements on the mutants that are defective in the 
allosteric response indicate that the same allosteric mechanism extends to the 
heterodimerization process. By contrast, measurements performed on mutants that 
perturb the homodimerization interface indicate that while some structural 
determinants are important for both interactions, select residues are exclusively 
critical for one but not the other. Overall these results indicate that against a backdrop  
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Figure 32. Residues investigated in Homodimerization and Heterodimerization 
The residues investigated are displayed on (A) experimentally determined structure of 
the homodimer (31) and (B) hypothetical structural model of the heterodimer (97). 
The β-sheet at the dimerization interface of both structures is highlighted in black.  
Figures were constructed using MolMol (28) with Protein Data Bank code 2EWN for 












of significant overlap of structural features that contribute equally to the two 
alternative protein:protein interactions, “hotspots” have evolved that are exclusive to 
one but not the other. 
 
B. Results 
1. Homodimerization of Mutant Repressor Proteins 
 The transcriptional repression function of BirA occurs through regulation of 
homodimerization. Bio-5’-AMP binding promotes biotin operator occupancy by 
enhancing repressor homodimerization. Results of previous studies indicate that while 
apoBirA dimerizes weakly in the millimolar concentration range, the BirA-bio-5’-
AMP complex exhibits relatively tight dimerization with a KD in the micromolar 
range of concentration of 6 ± 2 µM (17, 27). Thus the coupling free energy for 
dimerization associated with bio-5’-AMP binding is –4.0 kcal/mole. Solution studies 
and x-ray crystallographically determined structures have indicated that the BirA 
homodimerization interface is formed via a β-sheet in the central domain of each 
holoBirA monomer (30, 31). Moreover, the same surface on BirA is used in its 
interaction with apoBCCP (97). The purpose of this study is to investigate the overlap 
in structural determinants critical to both protein:protein interactions. Previous 
analysis of the self-assembly properties of a pool of mutants provided information 
about the structural features important for homodimer interaction (see below). In this 
study we characterize the homodimerization properties of four additional mutants. 
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 Analysis of the self-assembly properties of BirA mutants has revealed two 
classes of defects, including mutations that perturb the protein:protein interface and 
those that disrupt the coupling between bio-5’-AMP binding and dimerization. 
Among the BirA mutants at the homodimer interface are R118G and R119W. 
Sedimentation equilibrium measurements performed on the two proteins at saturating 
bio-5’-AMP concentrations revealed that they are characterized by very weak 
dimerization (32). Indeed, at concentrations at which the wild-type holoBirA is 
predominantly a dimer the two proteins were monomeric. However, measurements of 
total assembly of these mutants on bioO by DNase I footprint titrations allows 
estimation of their dimerization properties. As discussed in the introduction, the total 
assembly of holoBirA on bioO reflects dimerization followed by DNA binding. 
Assuming that for these mutants the energetic penalties associated with the total 
assembly reflect only the decreased dimerization energetics, the dimerization free 
energies for R118G and R119W are -3.4 and -2.2 kcal/mol, respectively (Table 9). 
Another mutant at the homodimer interface is A146∆ which exhibits defective 
dimerization energetics of -5.8 kcal/mol. Mutations in the adenylate binding loop, 
which is distal to the dimerization interface disrupt the coupling between bio-5’-AMP 
binding and dimerization. These allosteric mutants are at residues V214, V219 and 
W223 that form a hydrophobic cluster around the adenine ring of the adenylate 
ligand. Mutation of these residues to alanine results in energetic penalties for 
dimerization (∆∆G˚dim) of + 1 to +1.5 kcal/mol relative to the wild-type repressor 
(128) (Table 9).  
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In this work sedimentation equilibrium measurements were performed on four 
additional BirA mutants, two of which are in the BBL and two in the ABL. While 
these mutants were originally constructed for an unrelated study, they proved useful 
for these investigations. Residues R116 and K122 of the BBL are located in close 
proximity to the dimerization interface, and R212 and R213 of the ABL are 
positioned distal to the interface. All sedimentation equilibrium measurements were 
performed at three loading concentrations of each complex and the samples were 
subjected to centrifugation at three rotor speeds. In all cases the bio-5’-AMP 
concentration was sufficiently high to ensure saturation of the protein with ligand.  
The data obtained for R212A (Figure 33) was first analyzed using a single species 
model in order to obtain the average molecular mass of the complex. The data were 
then subjected to global analysis using a monomer-dimer association model to resolve 
the dimerization constants. The quality of the fit was assessed from the magnitude of 
the square root of the variance of the fit and the distributions of the residuals. Single 
species analyses indicated protein assembly for all proteins. The resolved equilibrium 
dissociation constants for the holoBirA variant complexes are shown in Table 9, 
indicate that BirA variant R116A and R213A exhibit dimerization energetics identical 
to the wild-type repressor. By contrast, BirA variants K122A and R212A demonstrate 






        
Figure 33. Absorbance versus radial position for 45 µM R212A.bio-5’-AMP at 
22,000 (◊), 26,000 (♦) and 30,000 (o) rpm obtained in standard buffer at 20 ˚C. The 
best-fit curves were generated from global analysis using a monomer-dimer model of 
six data sets acquired at multiple loading concentrations and spun at three speeds. The 
residuals of the fit for each data set shown are provided in the bottom panels.  
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Table 9. Homodimerization Properties of the BirA Variant – bio-5’-AMP Complexes 
BirA Variant Kdim (M) ∆G˚dim (kcal/mol) 
WT 6 ( ± 2) x 10-6 -7.0 ± 0.3 
R119W † 2.2 x 10-2 -2.2 
R118G  † 2.5 x 10-3 -3.4 
V219A  * 8 ( ± 1) x 10-5 -5.5 ± 0.2 
V214A  * 3 ( ± 1) x 10-5 -6.1 ± 0.2 
W223A * 3 ( ± 1) x 10-5 -6.1 ± 0.2 
K122A 2.1 ( ± 0.6) x 10-5 -6.2 ± 0.2 
R212A 1.5 ( ± 0.6) x 10-5 -6.4 ± 0.3 
R213A 7 ( ± 4) x 10-6 -6.9 ± 0.3 
R116A 5 ( ± 2) x 10-6 -7.1 ± 0.3 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods.  The reported values represent the average of at least two independent 
sedimentation equilibrium measurements performed by subjecting samples prepared 
at multiple loading concentrations of the variant-bio-5’-AMP complex to 
centrifugation at multiple rotor speeds. Each resulting data set was subjected to global 
analysis using a monomer-dimer model to determine KDIM. † Self-association 
properties for these variants were determined previously (32). ∆G˚dim values were 
estimated from total assembly energetics and do not have errors (see text for details). 
* Dimerization properties for these variants were previously reported (128). 
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2. Heterodimerization Properties of holoBirA Variant-apoBCCP Complexes 
 The mutants described above, (Figure 35A), were investigated for their 
abilities to form the heterodimer with apoBCCP. Direct measurement of 
heterodimerization in this system is not possible because interaction between 
holoBirA and apoBCCP results in chemical transfer of biotin to apoBCCP, a reaction 
that results in dissociation of the complex and conversion of holoBirA to apoBirA. 
Due to these limitations alternative methods for measuring heterodimerization have 
been developed. In the first method the heterodimer interaction is indirectly detected 
by monitoring the effect of apoBCCP on binding of holoBirA dimer to bioO. In the 
second method direct measurement of BirA-catalyzed biotin transfer to apoBCCP is 
used to assess the heterodimerization process. All of the mutants that were assessed 
for their homodimerization properties were subjected to these two measurements. The 
acceptor protein utilized in both measurements corresponds to a fragment of the 
acceptor protein, apoBCCP87, that is known to function identically to the intact 
protein in BirA-catalyzed biotin transfer (136). 
  
a. Inhibition DNase I footprinting Titrations: 
The heterodimerization interaction was measured using inhibition DNase I 
footprint titrations. Addition of apoBCCP87 to a mixture of holoBirA and bioO 
results in perturbation of holoBirA homodimerization required for bioO occupancy. 
As the concentration of apoBCCP87 is increased, the level of holoBirA dimer 
decreases, thus decreasing the fractional occupancy of bioO. Inhibition data obtained 
over a range of apoBCCP87 concentrations enables measurement of the equilibrium 
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inhibition constant for apoBCCP87. Previous studies reveal that the results obtained 
with this assay are in excellent agreement with those obtained from direct 
measurement of inhibition of holoBirA dimerization by apoBCCP (95). 
              
Design and analysis of the inhibition footprints required initial assessment of 
bioO binding by all the mutants using direct DNase I footprinting. Due to defects in 
catalysis of adenylate synthesis by some, these experiments were performed with 
preformed complexes of each mutant protein bound to chemically synthesized bio-5’-
AMP. Direct DNase I footprint titrations were first performed to determine the 
optimal holoBirA concentration for use in inhibition footprints. This holoBirA 
concentration, which corresponds to a value just below saturation of bioO, renders the 
system poised for perturbation by apoBCCP87 in the inhibition measurements. A 
representative footprint of BirA variant R213A binding to bioO is shown in Figure 
34A. Quantification of footprints yielded isotherms of fractional occupancy versus 
[holoBirA] that were subjected to non-linear least squares analysis using the 











=        …………………...(1) 
to obtain KTOT, the equilibrium association constant for total assembly of the 
holoBirA dimer:bioO complex from holoBirA monomer and bioO. Y is the fractional 
saturation of bioO, and KTOT is the product of equilibrium dimerization and bioO 
binding constants (KDIMKbioO). Figure 34B displays the binding isotherms and best-fit 
curve for BirA variant R213A. The KTOT determined for each mutant was used in 
analysis of the relevant inhibition footprint (see below). 
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The inhibition DNase I footprint is performed to measure the dependence of 
fractional saturation of bioO by holoBirA dimer on apoBCCP concentration. In these 
measurements the fractional occupancy of bioO is perturbed by an interaction 
between apoBCCP and a certain fraction of holoBirA. The holoBirA concentration is 
maintained at a single value and the apoBCCP concentration is increased. The 
mixtures are incubated for a short time of 60-80 second, and the DNA is then probed 
with DNaseI for occupancy by holoBirA. The short incubation time is used to avoid 
complications that would arise if the holoBirA were released from bioO and provided 
a second opportunity to interact with apoBCCP. The inhibition footprint obtained for 
K122A binding to bioO is shown in Figure 34C. Inspection of the gel image reveals a 
loss of the footprint with increasing apoBCCP concentration. Quantification of the 
footprint reveals an inhibition of fractional occupancy of bioO versus apoBCCP 
concentration. These data were subjected to non-linear least squares analysis using 


























=     ………………(2) 
Where KTOT is the equilibrium association constant for total assembly of the holoBirA 
dimer:bioO complex from holoBirA monomer and bioO and KI, the inhibition 
constant for apoBCCP and Y , the fractional saturation of bioO by holoBirA. 
Inspection of the equation the fractional occupancy of bioO decreases with increasing 
apoBCCP concentration. The inhibition constant, KI, provides a quantitative measure 




Figure 34. Direct and Inhibition DNase I Footprinting (a) Image of the gel obtained 
for DNase I footprinting of R212A with bioO. (b) Isotherm obtained from 
quantification of the data. The curve was generated from non-linear least squares 
analysis of data to equation (1) in text. (c) Image of the gel obtained for inhibition 
DNase I footprinting of K122A with bioO as a function of apoBCCP87 
concentration. (d) Isotherm obtained from quantification of the data. The curve was 
generated from non-linear least squares analysis of data to equation (2) in text.  
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Table 10. Inhibition of HoloBirA Variants Binding to bioO by ApoBCCP87 
BirA Variant KI (µM)
a ∆G˚I (kcal/mol) 
WT 2 ( ± 1) -7.6 ± 0.4 
R119W > 200 < -4.9 
R118G 14 ( ± 3) -6.5 ± 0.1 
V219A 26 ( ± 4) -6.1 ± 0.1 
V214A 10 ( ± 1) -6.7 ± 0.1 
W223A 8 ( ± 1) -6.8 ± 0.1 
K122A 12 ( ± 3) -6.6 ± 0.2 
R212A 7 ( ± 1) -6.9 ± 0.1 
R213A 7 ( ± 2) -6.9 ± 0.2 
R116A > 400 < -4.5 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in the Materials and 
Methods section, with the exception of BirA variant R119W which was performed 
under the same buffer conditions with 50 mM KCl. (a.) Footprinting data were fit to 
equation (2) In all analyses to determine KI the parameter, KTOT obtained from direct 
DNase I footprinting data, was fixed. All reported values represent the average of two 
independent measurements and errors represent 95% confidence intervals. Values for 
R119W and R116A are estimates and do not have errors because they were beyond 
the concentration regime used in these measurements. 
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Figure 35. Free energies of Homodimerization and Heterodimerization 
(A) ∆G˚Dim and (B) ∆G˚I of each holoBirA variant in colored bars, compared to that 
measured for the wild type repressor in white bar. Each variant is color coded as 
displayed in Figure 32. The reported values represent the average of at least two 
independent measurements and errors represent 95% confidence intervals.   
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Based on the results of inhibition titrations, the mutant repressors exhibit a 
range of affinities for apoBCCP87 (Table 10, Figure 35B). Data acquired for the 
wild-type is in excellent agreement with that previously reported. The KI values for 
the BirA variants range from 3 - 200 fold weaker than that determined for the wild-
type protein. The most striking results were obtained for BirA variants R119W and 
R116A, both of which showed no chamge in the level of bioO occupancy at 
apoBCCP concentrations as high as 300 µM.      
 
b. BirA-catalyzed biotin transfer to apoBCCP87: 
  The interaction between holoBirA and apoBCCP results in BirA-catalyzed 
chemical transfer of biotin from bio-5’-AMP to a specific lysine residue, K122, of 
apoBCCP. Time courses of this reaction can be monitored by measuring the time-
dependent incorporation of 14C-biotin into apoBCCP. Measurement of the initial rates 
of incorporation versus apoBCCP concentration allows Michaelis-Menten analysis to 
yield the Michaelis constant, KM, for the acceptor protein. However, in order to 
measure the apoBCCP-concentration dependence of biotin transfer, the other 
substrates, biotin and ATP should be at concentrations of maximal velocity. 
Therefore, biotin binding affinities and ATP-dependence of BirA-catalyzed syntheses 






(i) Biotin Binding to BirA Variant Proteins 
Biotin binding affinities of variant proteins were determined by equilibrium 
titration methods using isothermal titration calorimetry and steady-state fluorescence 
measurements as described in the Materials and Methods section. Representative data 
shown in Figure 36 were subjected to nonlinear least squares analysis using a single 
site binding model to obtain the equilibrium association constant, Ka for the process. 
The thermodynamics of biotin binding to the variant proteins are shown in Table 11.  
With the exception of BirA variant R116A, all BirA variants exhibited biotin binding 
thermodynamics identical to wild-type. This mutant exhibited 100 fold weaker 
binding affinity relative to the wild-type protein. The binding parameters for R118G 
and R119W, which were previously reported (139), are also shown in Table 11. 
 
(ii) ATP- dependence of BirA-catalyzed synthesis of Bio-5’-AMP 
 The initial rates of BirA-catalyzed synthesis as a function of ATP 
concentration was measured in order to determine the catalytic efficiency of bio-5’-
AMP synthesis from biotin and ATP. Synthesis of bio-5’-AMP follows an ordered 
kinetic mechanism, in which biotin binds and creates the ATP binding pocket. Biotin-
saturated BirA is mixed with ATP to produce BirA-bio-5’-AMP. Since the intrinsic 
fluorescence signal for the protein bound bio-5’-AMP is lower than that of the protein 
bound to biotin, the time-dependent decrease in fluorescence can be used to monitor 






Figure 36. Biotin Binding to BirA Variant R213A.  
Equilibrium titration ITC raw data (top panel) and isotherm (bottom panel) of biotin 
binding to BirA variant R213A. Measurement was performed in Standard Buffer (10 
mM Tris-HCl pH 7.50 ± 0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as 







Table 11. Thermodynamics of Biotin Binding to the BirA Variant Proteins 
BirA Variant Kb (M)
a ∆Go  (kcal/mol)b 
WT 4.3 ( ± 0.3) x 10-8 -9.84 ± 0.04 
R119W † 2.5 ( ± 0.3) x 10-7 -8.9 ± 0.1 
R118G † 1.8 ( ± 0.4) x 10-6 -7.7 ± 0.1 
V219A * 3.8 ( ± 1.0) x 10-8 -10.0 ± 0.2 
V214A * 3.8 ( ± 0.8) x 10-8 -9.9 ± 0.1 
W223A * 4.7 ( ± 0.4) x 10-8 -9.8 ± 0.1 
R116A ^ 1.4 ( ± 0.4) x 10-6 -7.8 ± 0.2 
K122A 4.4 ( ± 0.8) x 10-8 -9.8 ± 0.1 
R212A 3.9 ( ± 0.3) x 10-8 -9.89 ± 0.04 
R213A 4.1 ( ± 0.3) x 10-8 -9.9 ± 0.1 
Measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 0.02 
at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in the Materials and 
Methods section. The reported values represent the average of at least two 
independent titrations with standard deviation. a. Values of Kb are the best-fit values 
obtained from nonlinear least squares analysis of the titration data to a simple binding 
model using Origin or GraphPad Prism 4. b. The values of the Gibbs free energy, 
∆Go, were calculated using the expression ∆Go=RTlnKb. † Biotin binding 
thermodynamics for these variants were reported (139). * Biotin binding 
thermodynamics for these variants were reported in (128). ^ The equilibrium 
dissociation constant for binding biotin to R116A was determined from direct 
equilibrium fluorescence titrations. 
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trace obtained for BirA variant R212A synthesis of bio-5’-AMP at 500 µM ATP. 
This time-dependent fluorescence decrease could be analyzed using a single 
exponential model to obtain the initial rate of adenylate synthesis. The process 
monitored follows the mechanism: 
      
in which the holo BirA•biotin complex is in rapid equilibrium with the ternary 
complex of the enzyme bound to both substrates. Assuming that pyrophosphate 
release is very fast, the chemical step is described by k2. The initial rate increases with 
increasing ATP concentration. The dependence of the initial rate of bio-5’-AMP 
synthesis on ATP concentration is provided by the modified Michaelis-Menten 
equation: 











=υ           …………………(3) 
Where υo is the initial velocity, the maximal velocity is given by the expression, 
20][ kbiotinBirA•  and the KM(ATP) is equal to (k2 +k-1)/k1. Measurements are performed 
over a range of ATP concentrations at which [ATP] << KM. The dependence of the 
initial rate on ATP concentration is analyzed using a linear equation. The slope 
reflects the catalytic efficiency, kcat/KM or k2/KM for BirA-catalyzed bio-5’-AMP 
synthesis as a function of ATP concentration. The data obtained for each variant is 
shown in Figure 37B. Due to the exceedingly slow rate with which they catalyzed 
adenylate synthesis, values for BirA variants V219A and W223A were not 
determined. The values for the other variants, which are shown in Table 12 reveal that 
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they are similar to wild-type BirA in their abilities to catalyze synthesis of bio-5’-
AMP from biotin and ATP. Making the assumption that the kcat for each variant is 
similar to that of the wild-type protein, the KM for ATP is also considered similar to 
wild-type. The KM for ATP for the entire reaction for the wild-type is 400µM 
measured by the Michaelis-Menten kinetics assay described below. In this 
measurement the time-dependent 14C-biotin incorporation into apoBCCP is obtained 
at a saturation acceptor concentration over a range of ATP concentrations. The 
conditions used to measure KM for apoBCCP for the variants were performed at a 
concentration of 1mM ATP. 
 
(iii) Michaelis-Menten kinetics of biotin transfer to apoBCCP87:       
 Direct measurement of the Michaelis-Menten kinetics of BirA-catalyzed 
biotin transfer to apoBCCP is performed to assess the heterodimerization process. 
The time course of this reaction is monitored by measuring the time-dependent 14C-
biotin incorporation into apoBCCP. Biotin-saturated BirA was mixed with ATP and 
apoBCCP87 and the reaction was quenched at specific time intervals. Unincorporated 
14C-biotin was separated from biotinylated-BCCP87 (holoBCCP87) on a low 
molecular weight SDS-polyacrylamide gel. A representative image of a gel obtained 
from a time course carried at a single apoBCCP87 concentration is shown in Figure 
38A. The time-dependence of biotinylation is determined by quantification of the 
band corresponding to 14C-biotin-BCCP87 as a function of time. The data in the 
linear portion of the curve were subjected to linear least squares regression to obtain 
the initial velocity of BirA- catalyzed 14C-biotin transfer to apoBCCP87 at each  
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Figure 38. Stopped-flow fluorescence trace obtained for measuring BirA-catalyzed 
synthesis of bio-5’-AMP from biotin and ATP. (A) bio-5’-AMP synthesis by biotin-
bound BirA Variant K122A monitored by stopped-flow fluorescence. (b) The ATP 





Table 12. ATP-dependence of BirA catalyzed synthesis of bio-5’-AMP 
 
   
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in the Materials and 
Methods section. The reported values represent the average of at least two 









BirA Variant kcat /KM (M
-1s-1) 
WT 180 ± 10 
R116A 120 ± 10 
K122A 160 ± 10 
R212A 160 ± 10 
R213A 130 ± 10 
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concentration of acceptor protein. Similarly, the initial rates were obtained over a 
range of apoBCCP87 concentrations.The dependenceof initial rate on [apoBCCP87] 
was used to build a Michaelis-Menten plot as shown in Figure 38B. These data were 
subjected to non-linear least squares analysis using the Michaelis-Menten equation: 











           ………………...(4) 
to obtain the Michaelis constant, KM, for apoBCCP87.  
 
  The KM values for BCCP87 determined for wild-type BirA and variants are 
shown in Table 13.  Due to their inability to catalyze bio-5’-AMP synthesis at a 
reasonable rate, the KM values for BirA variants V219A and W223A were not 
determined. The KM for BCCP87 for the wild-type protein is 12 ± 5 µM. With the 
exception of R119W and R116A which exhibit KM values 12 to 14 fold higher, all 
variants are similar to the wild-type protein in biotin transfer to apoBCCP.  
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Figure 38. BirA-catalyzed 14C-biotinylation of apoBCCP87 
(a.) Representative gel of 14C-biotinylation of 10 µM apoBCCP87 as a function of 
time. (b.) Michaelis-Menten plot for biotinylation of apoBCCP87. Vo represents 
counts of 14C-biotin/second. The data were acquired at 150 µM BirA variant R212A, 
1 mM ATP, and 10 µM 14C-biotin in standard buffer conditions as described in the 
Materials and Methods section.  
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Table 13. Michaelis-Menten Kinetics of BirA catalyzed biotin transfer to apoBCCP87 
BirA Variant KM (µM)
a 
WT 12 ± 5 
R119W 165 ± 30 
R118G 6 ± 3 
V219A n.d.* 
V214A 7 ± 2 
W223A n.d.* 
K122A 6 ± 2 
R212A 9 ± 2 
R213A 7 ± 3 
R116A 150 ± 25 
 
All measurements were performed in Standard Buffer (10 mM Tris-HCl pH 7.50 ± 
0.02 at 20.0 ± 0.1 oC. 200 mM KCl, 2.5 mM MgCl2) as described in Materials & 
Methods. The reported errors represent 95% confidence intervals of the fit, except the 
reported value for BirA wild-type which is the average of two independent 
measurements. (a) KM values are obtained from non-linear least squares fits of the 
data to equation (3) * KM for BCCP87 for BirA variants V219A and W223A were not 





The E.coli Biotin Regulatory System provides an excellent model for 
investigating how the functional fate of a single protein is regulated by formation of 
alternative protein:protein interactions. The central component of this system, BirA, 
funnels biotin into metabolism or regulates biotin biosynthesis by switching between 
two alternate interactions (2, 3). It can homodimerize or form a heterodimer with 
apoBCCP, a subunit of the acetyl-CoA carboxylase (ACC) enzyme. While the former 
process results in transcription repression the latter results in biotin transfer to ACC, 
the enzyme that catalyzes the first committed step of fatty acid synthesis. 
Thermodynamic analyses indicate that the two processes are iso-energetic and that 
the functional switch in BirA is kinetically controlled (27, 95, 96). Structural data 
indicate that a single surface on BirA is used for both homo- and heterodimerization 
(30, 31, 97). Thus the two protein:protein interactions are mutually exclusive. While 
both interactions use the same BirA surface and are isoenergetic, the different 
response of the two interactions to bio-5’-AMP analogues and change in temperature 
provide preliminary evidence that the detailed chemistries of the interactions differ 
(29, 107). In this study, comparison of the two interactions using wild type and single 
site mutants of BirA reveal that significant overlap in the structural requirements of 
the two interactions exists. 
     
 Structural elements on BirA required for wild type homodimerization 
energetics were previously studied by thermodynamic characterization of BirA 
mutants. The results revealed two classes of mutants, including those that directly 
 148 
disrupt the protein:protein interface and those that perturb the thermodynamic 
coupling between bio-5’-AMP binding and dimerization. Structures of BirA indicate 
that three of the loops located in the central domain of BirA participate directly at the 
dimerization interface. One of the loops at the interface is the biotin binding loop 
(BBL), which contains a five residue glycine/arginine rich sequence that is conserved 
in all biotin holoenzyme ligases thus far sequenced. Mutants R118G and R119W in 
this loop exhibit defects of +3.6 and +4.8 kcal/mol. In addition to the BBL, loops 
composed of residues 193-199 and 140-146 are located at the homodimer interface. 
The two mutants D197A and A146∆ exhibit defects in dimerization of +4.5 and +2.2 
kcal/mol. A fourth loop, the adenylate binding loop (ABL) is distal to the 
dimerization interface. Structural data indicate that the loop folds around the 
adenylate moiety of the adenylate ligand and that the residues V219, V214 and W223 
form a hydrophobic cluster over the adenine ring of the ligand (31). Thermodynamic 
analyses of variant proteins V214A, V219A and W223A, indicate that disruption of 
this hydrophobic cluster moderately compromises dimerization energetics (128). In 
this study the homodimerization properties of four additional variants in the ABL and 
BBL are presented. Relative to the wild-type protein, mutation of residues R212 and 
K122 to alanines results in +0.6 kcal/mol and +0.8 kcal/mol defect in free energy of 
dimerization, respectively. By contrast, BirA variants R116A and R213A exhibit 
wild-type dimerization energetics. These measurements of the self-assembly 
properties of this pool of mutants provide information about the structural 
determinants required for both direct formation of the protein:protein interface and 
allosteric activation of the dimerization process. The mutants also provide a means of 
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investigating the structural determinants on BirA required for heterodimerization with 
apoBCCP. 
  
 Heterodimerization properties of BirA variants were probed by two methods. 
The first employs the inhibition DNase I footprint titration technique, in which the 
apoBCCP87 concentration dependence of inhibition of occupancy of the biotin 
operator by holoBirA reveals an inhibition constant, KI, for apoBCCP87. This 
inhibition constant provides information about the strength of the interaction between 
holoBirA and apoBCCP87. The wild-type protein exhibits a KI of 2 ± 1 µM. In the 
second method the kinetics of BirA-catalyzed linkage of biotin to apoBCCP are 
measured. The incorporation of 14C-biotin into apoBCCP87 is monitored as a 
function of time over a range acceptor protein concentration to generate a Michaelis-
Menten plot. The Michaelis constant, KM for apoBCCP87, provides information about 
the affinity of holoBirA for apoBCCP assuming that formation of the product is the 
rate-limiting step. The KM value determined for the reaction catalyzed by wild-type 
BirA is 12 ± 5 µM. While both methods provide valuable information, the KI value 
obtained from the inhibition experiment is in excellent agreement with that 
determined by another indirect measurement of the heterodimer interaction. This 
method utilized sedimentation velocity to measure the perturbation of holoBirA self-
association by apoBCCP (95). The assumptions made in the analysis of both methods 
are similar. Moreover, the KI value is representative of the perturbation of 
homodimerization by apoBCCP, while the KM represents the entire chemical reaction 
that involves bio-5’-AMP synthesis and subsequent transfer of biotin to apoBCCP87. 
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   The Michaelis constant for apoBCCP has been measured previously by 
stopped-flow fluorescence (136). These measurements revealed a KM for apoBCCP of 
300 µM, a value approximately 30 times higher than that reported in this work. The 
former method measures the KM for the entire reaction that includes two half 
reactions; bio-5’-AMP synthesis and subsequent biotin transfer from holoBirA to 
apoBCCP. By contrast, since measurements are performed with BirA preloaded with 
bio-5’-AMP, the latter measures only the second half reaction. The stopped-flow 
measurements revealed biphasic kinetics of biotin transfer, in which the first phase is 
dependent on apoBCCP87 concentration and the second is concentration independent. 
The first phase reflects substrate binding and subsequent biotin transfer and the 
second reflects product release. At low apoBCCP87 concentrations, the rate of the 
apoBCCP concentration dependent phase overlaps with that of the concentration 
independent phase. Since the rates cannot be deconvoluted, the dependence of initial 
velocity on apoBCCP concentration at low [apoBCCP] in the Michaelis-Menten plot 
is absent. As a consequence, the KM for apoBCCP obtained from fitting Michaelis-
Menten data is over estimated. Overall, it is evident that the 14C-biotin assay utilized 
in this study provides an accurate KM for apoBCCP and is in reasonable agreement 
with reported KI values, in measuring the heterodimer interaction. However, defective 
bio-5’-AMP synthesis properties for some of the mutants precluded measurement of 
the KM for apoBCCP by this kinetic assay. 
 
 BirA mutants investigated for homodimerization properties were examined for 
their effects on heterodimerization. Based on the results of the inhibition experiment, 
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the variants V214A, V219A, W223A exhibited defects of 4- 13 fold in KI values and 
are thus moderately defective in heterodimerization. BirA variants R212A and 
R213A of the ABL are characterized by KI s approximately 3.5 fold greater than wild-
type BirA and are modestly defective. Mutation of residues K122 and R118 of the 
BBL result in 6 and 7 fold defects in heterodimerization, respectively. However, the 
most dramatic defects are observed with the BirA variants R119W and R116A. For 
both variants concentration as high as 200 µM apoBCCP87 did not perturb the 
equilibrium occupancy level of bioO. Results of the 14C-biotin assay revealed that all 
BirA variants exhibited similar KM values as that of the wild-type protein, with the 
exception of BirA variants R119W and R116A. These variants indicate 12-14 fold 
higher KM values in comparison to wild-type. While these values do not directly 
correlate in magnitude with defects in heterodimerization observed by the inhibition 
experiment, it is noteworthy that both assays indicate that the most pronounced 
defects are observed with variants R119W and R116A. Taken together, results 
indicate a range of defects in heterodimerization properties of variant proteins and 
provide information on the structural determinants integral to the interaction between 
holoBirA and apoBCCP.  
 
Residues located distal to the dimerization interface contribute important 
structural determinants to both dimerization interactions. These include residues of 
the hydrophobic cluster (V214, V219, W223) in the ABL and K122 located in the 
biotin binding loop. Disruption of K122 affects both dimerization interactions to 
similar extents. While homodimerization of K122A is characterized by 3.8-fold 
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higher KD, the KI for apoBCCP87 is 6 fold higher than that measured for the wild-
type protein. Structural data suggest that K122 may contribute to stacking interactions 
that accompany folding of the biotin binding loop (31). Mutations of the hydrophobic 
cluster of the ABL perturb the allosteric activation of homodimerization by bio-5’-
AMP. Measurements of the heterodimerization interaction were limited to the 
inhibition DNase I footprinting technique. Nevertheless, the determined inhibition 
constants indicated a striking correlation in the involvement of these residues in both 
protein:protein interactions. Relative to the wild-type protein, variants V214A, 
V219A and W223A exhibited 5-14 fold higher KD values for homodimerization. The 
magnitudes of defects in homodimerization were mirrored in those of 
heterodimerization, represented by 4-13 fold higher KI values for apoBCCP87. These 
results lead to the conclusion that the allosteric signal in BirA associated with bio-5’-
AMP binding is positively coupled not only to homodimerization but also to 
heterodimerization.  
 
The most striking structural features important to both protein:protein 
interactions  are contributed by residues located at or close to the dimerization 
interface. These residues are part of the glycine rich sequence, 115GRGRXG120 in 
BirA, conserved in all biotin holoenzyme ligases (141). Phenotypic analysis of E. coli 
strains that carry mutations in this sequence, G115S and R118G, indicate that they 
require higher biotin concentrations for survival (3, 142). Biochemical studies on 
BirA variants R116A, R118G and R119W have demonstrated over one thousand fold 
defects in biotin binding affinities relative to the wild-type repressor (33). 
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Additionally, the structure of the ligand-bound dimer indicates that these residues are 
located in the biotin binding loop that orders over the biotin moiety. These data 
support a uniformly integral role for the residues of this sequence in biotin binding. 
However, despite their close proximity to the interface their involvement in 
alternative dimerization interactions is diverse. While residues R118 and R119 
participate directly at the homodimer interface, R116 contributes main-chain 
hydrogen bonds to the ureido ring of the biotin moiety. Although R118 is located at 
both protein:protein interfaces, it is selectively integral to the homodimerization 
interaction. By contrast, R116 is critical only for the apoBCCP87:holoBirA 
interaction. It is noteworthy, that both residues are conserved in the glycine rich 
sequences of all ligases. Residue R119 is not conserved within the sequence, yet is 
integral to both protein:protein interactions. Single site replacement of R119 with 
tryptophan severely disrupts both homo- and hetero-dimerization. These biochemical 
measurements are supported by structural data. Inspection of the dimer interface of 
the homodimer reveals an intermolecular salt bridge between R119 of one holoBirA 
monomer and D197 of the other. Previously solution studies have shown that 
mutation of either of these residues dramatically disrupts homodimerization (32). 
Furthermore, the model of the heterodimer indicates interaction between R119 of 
holoBirA and residue E169 of apoBCCP87. Thus R119 serves as an essential 
“hotspot” in both protein:protein interfaces.  
 
There are many biological processes in which a single protein participates in 
functional switching via alternative protein:protein interactions. In a subset of these 
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systems structural data indicate use of one surface on one of the partners for both 
interactions, thus rendering the processes mutually exclusive. Amongst others, many 
transcriptional regulators posses an additional biological function regulated through 
interaction with another protein partner. In this study we have addressed one such 
transcription factor, the E. coli biotin repressor, BirA. The primary focus was to 
determine the structural features important for its alternative protein:protein 
interactions. Biochemical characterization of mutant proteins has provided a map of 
residues on BirA that are important for hetero- and homo-dimerization processes. The 
results indicated a range of defects in both dimerization properties for the variants 
(Figure 39). While there is significant structural overlap in both protein:protein 
interactions, residues exclusively critical to a one but not the other dimerization 
process have been identified. Those structural features that function in allosteric 
activation of homodimerization by bio-5’-AMP also extend to heterodimerization. By 
contrast, measurements performed on mutants that perturb the homodimerization 
interface indicate that while some structural determinants are important for both 
interactions, select residues are exclusively critical for one but not the other. Overall 
these results indicate that against a backdrop of significant overlap of structural 
features that contribute equally to the two alternative protein:protein interactions, 






   
 










Figure 39. Overlap in Structural Determinants important to Homodimerization and 
Heterodimerization. The defects observed upon mutation of depicted residues on (A) 
homodimerization and (B) heterodimerization range from modest (blue) to dramatic 
(red). Residues marked with a yellow star are exclusive to one but not the other 











VI.  Materials and Methods 
 
A. Chemicals and Biochemicals 
All chemicals used in the preparation of buffers were obtained commercially 
and were at least reagent grade. The d-biotin, isopropyl β-D-thiogalactoside (IPTG), 
polyethyleneimine (PEI), adenosine triphosphate (ATP), DNase I, and subtilisin A 
were purchased from Sigma. The Klenow fragment of DNA Polymerase I and 
restriction enzymes, Hind III and Pst I were from Promega. The α32P dATP and 
dGTP used for radioactive labeling of DNA, and the 14C-biotin were obtained from 
GE Healthcare or Perkin Elmer. The bio-5'-AMP was synthesized and purified in the 
laboratory using a published procedure (5). The biotinol- adenylate (btnOH-AMP) 
was synthesized as described in Brown et al (29). The truncated biotin carboxyl 
carrier protein (apoBCCP) was purified as described in Nenortas and Beckett (136), 
with the exception of an additional chromatography step at the end, on a 
Hydroxyapatite ULTROL (PALL). This was performed to remove trace quantities of 
the DNase I that were introduced during purification. BCCP87, the C-terminal 
domain of BCCP, has been shown to function as the intact protein in biotin transfer in 
Nenortas and Beckett (136).  
 
B. Expression and Purification of BirA variants 
The BirA variants were expressed in the E. coli strain JM109 transformed 
with the plasmid pBtac2 carrying the E. coli birA gene (wild type or mutant) under 
transcriptional control of the tac promoter. The gene was altered to encode a C-
 158 
terminal (His)6 tag, which does not interfere with the protein’s function (32). Cells 
were grown at 30oC in LB media and protein expression was induced by addition of 
IPTG at O.D.600nm of 0.6-0.9 for 3 hours. The cells were harvested by centrifugation 
and lysed by sonication. After separation of the cell debris from the lysate by 
centrifugation, nucleic acids were removed by addition of PEI to a final concentration 
of 0.2% (vol/vol). The separation and purification of BirA from other cellular proteins 
was carried out in two chromatography steps. The protein mixture was applied to a 
NiNTA (Qiagen) column (150 mm x 15 mm) equilibrated with 20 mM imidazole, 50 
mM (NaH)PO4, 300 mM NaCl, 5% glycerol, 0.1 mM DTT, pH 8.0 and eluted with a 
step gradient of increasing imidazole concentration from 20 mM to 175 mM in the 
same buffer. With the exception of BirA V219A, K122A, R212A and double mutant 
R212A/R213A, fractions containing BirA were pooled and dialyzed against SP-
Sepharose Starting Buffer (50 mM Tris-HCl (pH 7.5 at 4 oC), 50 mM KCl, 5% 
glycerol, 0.1 mM DTT) and loaded onto a SP-Sepharose (GE Healthcare) column 
(150 mm x 15 mm) equilibrated with the same buffer. Protein was eluted in a linear 
KCl gradient (0.05 M to 0.8 M) in 50 mM Tris-HCl (pH 7.5 at 4 oC), 5% glycerol, 0.1 
mM DTT. The fractions containing pure BirA were pooled and dialyzed against 
Storage Buffer (50 mM Tris-HCl (pH 7.5 at 4 oC), 200 mM KCl, 5% glycerol) and 
stored at –70 oC.  Fractions containing BirA for purification of variants V219A, 
K122A, R212A and double mutant R212A/R213A were pooled, dialyzed against SP-
Sepharose Starting Buffer and loaded onto a Q-Sepharose (GE Healthcare) column 
(150 mm x 15 mm) and flow through containing the protein was collected. The pure 
protein was exchanged into Storage Buffer and stored at –70 oC. The yield for each 
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protein was > 12 mg/L of culture. The concentration of each protein stock was 
determined spectrophotometrically using a molar extinction coefficient at 280 nm 
calculated for each BirA histag variant using the method by Gill and von Hippel 
(143). The pooled protein sample for each BirA histag variant was >95% pure as 
judged by 12.5 % SDS-PAGE followed by Coomassie brilliant blue staining. Binding 
activity was >90% for all variants as determined by stoichiometric titrations with bio-
5'-AMP monitored by fluorescence spectroscopy (5) and described under the section 
on steady-state fluorescence measurements. 
 
C. Isothermal Titration Calorimetry 
All titrations were performed using a VP-ITC microcalorimeter with a 1.44 
mL sample cell volume, a 250 µL syringe, and equipped with a thermovac degasser 
(MicroCal, Inc., Northampton, MA.). The protein sample was dialyzed several times 
against standard buffer (10 mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 oC), 200 mM 
KCl, 2.5 mM MgCl2). The sample was filtered through a 0.22 µm PTFE syringe filter 
and the concentration determined spectrophotometrically using the ε280nm calculated 
for each variant. The dialysis buffer was filtered and used for protein and ligand 
sample preparation and degassed prior to use in the calorimeter. Titrations were 
performed by addition of ligand to protein in the sample cell. The heat of binding for 
each injection was obtained after subtracting the average heat of dilution obtained 
from multiple injections after the saturation of protein. The binding data were 
analyzed using Origin 7.0 software to obtain binding isotherms and thermodynamic 
parameters.  
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1. Equilibrium Binding Titrations 
a. Direct Titrations: 
The biotin binding thermodynamics of wild type and all variant proteins was 
determined by direct titration. With the exception of bio-5’-AMP and btnOH-AMP 
binding to wild type BirA, variants K122A, R212A, and R213A, direct titrations were 
employed for measurement of ligand binding to all other variant proteins. A 2 µM 
BirA (wild type or variant) solution was titrated with 25 10 µl injections of 20 µM 
ligand (biotin, bio-5’-AMP or btnOH-AMP) in standard buffer at 20.0 ± 0.1 oC. In all 
titrations the c values (KMtotn where K is the equilibrium association constant for the 
binding processes, Mtot is the total molar protein concentration in monomer units, and 
n is the stoichiometry of the binding interaction) fall within the range of 100-330. 
This range is below the upper limit of 500 recommended for measuring equilibrium 
constants. The signals were integrated and non-linear least squares analysis of binding 
data was performed using a single site binding model to obtain the equilibrium 
association constant, Ka, the binding enthalpy, ∆Ho, the stoichiometry, n.  






































               (i)
  
in which, Q is the total heat content after the ith injection, Xt is the total ligand 
concentration, Mt is the total protein concentration, Vo is the reaction volume. The 
total heat content is corrected for the change in reaction volume after each injection.  
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The Gibbs free energy, ∆Go and entropic contribution to each binding process, -T∆So, 
were calculated using these relationships, 
∆Go = -RTln KA                  (ii) 
    ∆Go = ∆Ho- T∆So                                      (iii) 
 
b. Displacement Titrations: 
The tight binding of bio-5’-AMP and/or btnOH-AMP to wild type BirA and 
variant proteins K122A, R212A, and R213A necessitated use of the displacement 
titration method (105) for measuring these interactions. In this technique the protein 
is first saturated with a weaker binding ligand, biotin, through a direct titration as 
described above and then displaced by btnOH-AMP or bio-5’-AMP. The titrations are 
performed with 25 x 10µL injections of 40µM biotin into 2µM BirA and then 
followed by the displacement titration of 35 x 7µL injections of 20µM btnOH-AMP/ 
bio-5’-AMP into the BirA•biotin solution. The raw data obtained are integrated and 
corrected for ligand dilution. The binding isotherm is then subjected to non-linear 
least squares analysis using a single-site binding model. The thermodynamic 
parameters obtained are the apparent binding constant, Kapp, and the apparent binding 
enthalpy, ∆Happ. The parameters are then used with the displacement model to obtain 
the equilibrium binding constant, KA, and the binding enthalpy, ∆HºA, for the tighter 
binding ligand, using the following relationships: 

















∆Η−∆Η=∆Η oo                       (v) 
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where, KB and ∆HºB are the equilibrium binding constant and binding enthalpy, 
respectively, of the lower affinity ligand, biotin, obtained through the direct titration 
method. [B] refers to the total biotin concentration in the sample cell. 
 
2. Total Association at Partial Saturation Titrations 
Titrations under conditions of total association at partial saturation were used 
to obtain measurements of the enthalpy of each binding process used in calculation of 
the heat capacities. In this method, 15 injections of a concentrated ligand solution are 
introduced into the protein solution under stoichiometric binding conditions. A 2 µM 
BirA (wild type or variant) solution is titrated with 5 x 5 µL injections of a 20 µM 
ligand (biotin, bio-5’-AMP or btnOH-AMP) in standard buffer at 20.0 ± 0.1 °C, 
followed by a 150 µL injection to saturate the protein, and finally followed by 8 x 5 
µL injections. The first five injections provide measurements of the uncorrected 
binding enthalpies (binding + ligand dilution), while the 8 injections post-protein 
saturation provide the enthalpy of ligand dilution. The enthalpy of binding is 
calculated using the equation, 
  ∆Hºbinding = ∆Hºbinding + dilution - ∆Hºdilution               (vi) 
In each experiment five measurements of the binding enthalpy are obtained.  
 
D. Heat Capacities of Ligand Binding 
Heat capacity changes associated with formation of the protein-ligand 
complexes were determined by measuring the temperature dependence of the binding 
enthalpy for the processes. Measurements were performed using the TAPS method 
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(see above) to obtain enthalpies of binding for wild type BirA and the three ABL 
variants with biotin, bio-5’-AMP, and btnOH-AMP at temperatures from 5-20 °C. 
The pH of the standard buffer was adjusted to 7.50 ± 0.02 at each working 
temperature. The heat capacity change upon binding was obtained by linear 
regression of the ∆Ho versus T data for each binding interaction, with this 
relationship: 







=∆                 (vii) 
 
E. Sedimentation Equilibrium 
Sedimentation Equilibrium Measurements 
The dimerization properties of each BirA variant-ligand complex bound to 
btnOH-AMP or bio-5'-AMP were determined by analytical ultracentrifugation using a 
Beckman Optima XL-I Analytical Ultracentrifuge equipped with a four-hole An-60 
Ti rotor (Beckman Coulter). Double-sector cells with charcoal-filled epon 
centerpieces with sapphire windows and optical pathlengths of 3 mm and 12 mm 
were employed (17). The protein was exchanged into and preequilibrated with 
standard buffer (10 mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 oC), 200 mM KCl, 2.5 
mM MgCl2) using a MicroBiospin 6 Chromatography column (BioRad). The 
concentration of the protein sample was determined spectrophotometrically using the 
ε280 calculated for each BirA variant. The complex was prepared in standard buffer at 
stoichiometric conditions with a ratio of 1:1.5 of protein to ligand. The buffer density 
(1.007 g/ml) was determined pycnometrically and the partial specific volume of BirA 
monomer is 0.755 ml/g as reported previously (17). Scans of absorbance versus radial 
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position were obtained at 295 nm at three protein loading concentrations from 15 µM 
to 75 µM and rotor speeds of 18,000, 22,000, 26,000, and 30,000 rpm for 12 hours 
each. Five measurements were acquired at each radial position with 0.001 cm 
spacing.  
 
Analysis of Sedimentation Equilibrium Data 
The sedimentation equilibrium data were subjected to non-linear least squares 
analysis using the programs MacNonLin (144) or WinNonLin. The σ-values were 




RT                          (viii) 
in which M is the molecular weight, v  is the partial specific volume of the protein, ρ  
is the density of the buffer, ω  is the angular velocity of the rotor, R is the gas constant 
and T is the temperature in Kelvin.  Data were also analyzed globally to a monomer-
dimer association model (145) to obtain the monomer-dimer association constant, Ka. 














             (ix) 
where δc is the baseline offset, ct is the total concentration at each radial position, r, 
cm(ro) is the monomer concentration at ro, ro is the reference radial position (at the 
first data point), σmon is the reduced molecular weight of the monomer determined by 
sedimentation of the aporepressor, and Ka is the equilibrium association constant 
governing assembly of the dimer from the monomers. In the analysis, the reduced 
molecular weight of the dimer is assumed to be twice that of the monomer. The 
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quality of each global analysis was evaluated by the magnitude of square root of 
variance of fit and distribution of residuals. 
 
F. Measurements of Rates of Subtilisin-catalyzed Proteolysis 
All BirA histag WT and variant samples were subjected to subtilisin-catalyzed 
proteolytic digestion following a 30 minute incubation at 20 ˚C in standard buffer (10 
mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 ˚C), 200 mM KCl, 2.5 mM MgCl2) either 
in the absence or presence of saturating concentrations of biotin or bio-5'-AMP.  The 
apparent rates of subtilisin-catalyzed cleavage were measured by addition of subtilisin 
prepared freshly in standard buffer to a BirA solution to obtain a final weight ratio of 
repressor:subtilisin of 33 to 50:1 and incubation was continued at 20 ˚C. All 
experiments were performed at a BirA concentration at which the protein is 100% 
monomeric in the absence and presence of ligand. A 10 µL aliquot was removed at 15 
minute time intervals and the reaction was quenched into 1 µL of 100 mM PMSF 
freshly prepared in absolute ethanol. Six microliters of Laemmli gel sample buffer 
were added and the proteolytic digestion products were separated by electrophoresis 
on a 15% SDS-polyacrylamide gel. Protein bands were stained with Coomassie 
Brilliant Blue and the amount of intact BirA for each time point of proteolytic 
cleavage was quantified using a Molecular Dynamics Laser Scanning Personal 
Densitometer. Control experiments have shown that high concentrations of the 





The rates of subtilisin-catalyzed cleavage of BirA were obtained by relating 
the time-dependent decrease of intact BirA to a pseudo-first order process. The 
apparent rates of proteolysis were estimated from linear least-squares analysis using 




) = −kt      (x) 
where [BirAOD]t  and [BirAOD]t=0  are the integrated optical densities for the bands 
corresponding to intact BirA at time t and the zero time point, respectively, t is time 
in minutes and k, is the rate or slope of the line.  
 
G. DNase I Footprinting 
1. Preparation of DNA for Footprinting 
The plasmid pBioZ was digested with Hind III. The purified and linearized 
DNA was radiolabelled with 32P- dATP and dGTP and chased with cold dNTPs using 
the Klenow Fragment (5, 146). The resulting labeled DNA was purified using an 
Elutip column (Scheicher and Schuell), and phenol-chloroform extracted. The 
mixture was ethanol precipitated followed by digestion with PstI.  The desired 
restriction fragment containing bioO, was isolated by electrophoresis on a 1% agarose 
gel and recovered by electroelution (146). The precipitated, radiolabelled DNA was 
resuspended to a final concentration of approximately 20,000 cpm/µl in TE buffer 
and stored at 4 º C. 
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2. Direct DNase I Footprint Titrations 
The DNase I footprint titrations were carried out in reaction buffer containing 
10 mM Tris-HCl (pH 7.5 ± 0.02 at 20  ± 0.1 °C), 200 mM KCl, 2.5 mM MgCl2, 1.0 
mM CaCl2, 100 µg/mL BSA, 2 µg/mL sonicated calf thymus DNA and ligand, 40 
µM bio-5’-AMP.  This was followed by preparation of 200 µL reaction buffer, along 
with 12000 cpm of radio-labeled DNA to a final concentration of approximately 20 
pM. Footprints were carried out with BirA at a range of concentrations. A DNase I 
solution of 3 µg/mL was prepared in 10 mM Tris-HCl (pH 7.5 ± 0.02 at 20  ± 0.1 °C), 
200 mM KCl, 2.5 mM MgCl2, 1 mM CaCl2.  DNA digestion was initiated and 
followed by quenching with 33 µL of a 50 mM Na2EDTA solution. The DNA was 
then precipitated with 700 µL of 0.4 M NH4OAc, 50 µg/ mL yeast phenylalanyl 
tRNA in ethanol and incubated in a dry ice/ ethanol bath for about 20 mins (16). The 
samples were centrifuged and pellets are washed with 80% (v/v) ethanol and dried 
down. The pellets were resuspended in a loading buffer and DNA fragments were 
resolved by electrophoresis on a 10% denaturing polyacrylamide gel (19:1 
acrylamide/ bisacrylamide in 8 M urea).   
 
3. Inhibition DNase I Footprint Titrations 
 DNase I footprinting was employed to probe the effect of increasing 
concentration of apoBCCP87 on the equilibrium level of holoBirA occupancy of 
bioO for the variant repressors. The careful selection of the holoBirA protein 
concentration for each variant protein at a value just below complete fractional 
saturation of bioO, was determined from direct DNase I footprinting measurements. 
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All reactions were performed in buffer containing 10 mM Tris-HCl (pH 7.5 ± 0.02 at 
20  ± 0.1 °C), 200 mM KCl, 2.5 mM MgCl2, 1.0 mM CaCl2, 100 µg/mL BSA, 2 
µg/mL sonicated calf thymus DNA and saturating concentration of bio-5’-AMP for 
each variant protein. A range of apoBCCP87 concentrations were used and in each 
sample apoBCCP87 was combined in buffer with 12,000 cpm labeled bioO to a total 
volume of 45 µL. The reaction was initiated with the addition of 5 µL of holoBirA to 
bring both proteins to the desired final concentrations. After a short incubation of 80 
seconds, 5 µL of a 0.0055 mg/mL DNaseI solution was added to each reaction 
followed by a 20 second digestion and quenched with 33 µL of 50 mM Na2EDTA. 
Precipitation was carried out with 700 µL of 0.4 M NH4OAc, 50 µg/ mL yeast 
phenylalanyl tRNA in Ethanol and incubated in a dry ice/ethanol bath for 20 minutes 
(16). The samples are centrifuged and pellets are washed with 80% (v/v) Ethanol and 
dried down. The pellets are resuspended in a loading buffer and DNA fragments 
separated by electrophoresis on a 10% denaturing polyacrylamide gel (19:1 
acrylamide/ bisacrylamide in 8 M urea). For those footprints performed in low salt 
buffer conditions (10 mM Tris-HCl (pH 7.5 ± 0.02 at 20  ± 0.1 °C), 75 mM KCl, 2.5 
mM MgCl2, 1.0 mM CaCl2, 100 µg/mL BSA, 2 µg/mL sonicated calf thymus DNA), 
0.002 mg/mL DNaseI was added to the reaction. 
 
4. Quantification and Data Analysis 
The gels were dried and exposed to storage phosphor screens for 40 hours or 
more. Footprints were imaged using a Storm phosphorimaging system (Molecular 
Dynamics) and the program Image Quant. The optical densities of bands 
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representative of the bioO binding site at each protein concentration were integrated 
to produce binding isotherms as described in Brenowitz et al (147). The binding data 
were analyzed by non-linear least squares analysis using the GraphPad Prism 4.0 











=                (xi) 
where Y is the fractional occupancy of the bioO site. The data are fit to obtain KTOT, 
the equilibrium constant for total assembly of the holoBirA dimer:bioO complex 
which is the product of the equilibrium dimerization constant, obtained from the 
analysis of sedimentation equilibrium data and the equilibrium constant governing 
dimer binding to bioO, KDIMKbioO. The magnitude of total free energies of assembly, 
∆GºTOT was calculated using the expression:      
      ∆GºTOT= -RTlnKTOT                (xii) 
The quality of the fits was assessed by the magnitude of the sum of the squares of the 
residuals and the distribution of the residuals. 
 
Similarly, with a modification of the above binding relationship, the fractional 
saturation of the operator site, bioO, by the repressor was determined as a function of 
apoBCCP87 concentration. In these competition experiments the fraction occupancy 
of bioO is perturbed by an interaction between apoBCCP and a certain fraction of 
holoBirA. The fractional saturation of bioO is 1.0 at the holoBirA concentrations used 
in these footprints. Hence the fractional occupancies obtained in the presence of 
apoBCCP were normalized relative to the value obtained in the absence of apoBCCP. 
The inhibition curve obtained for holoBirA binding to bioO in the presence of 
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apoBCCP is analyzed by non-linear least squares analysis using GraphPad Prism 4.0 


























=            (xiii) 
KI, the inhibition constant, is representive of the heterodimeric interaction between 
holoBirA and apoBCCP. Hence the fractional saturation of holoBirA by apoBCCP is 
dependent on both the KI  and the apoBCCP concentration.  
 
H. Steady-State Fluorescence Measurements 
 Stoichiometric and equilibrium titrations of certain variant proteins with the 
ligands biotin and bio-5’-AMP were performed by steady-state fluorescence using an 
ISS-PC1 spectrofluorimeter (ISS, Champaign, IL) equipped with a VWR Scientific 
1160 constant temperature bath (PolyScience, Niles, IL) maintained at 20.0 ± 0.1 °C.  
The excitation wavelength was 295 nm and the emission was monitored from 310-
450 nm, with both slit widths set at 0.5 nm. All titrations were performed in standard 
buffer (10 mM Tris-HCl  (pH 7.50 ± 0.02 at 20.0 ± 0.1 ˚C), 200 mM KCl, 2.5 mM 
MgCl2) at 20.0 ± 0.1 °C.  Measurements were performed by sequential addition of 
concentrated biotin or bio-5’-AMP to 600-800 µL of 1-2 µM apo BirA sample. A 
spectrum of the apo protein is recorded, followed by acquisition of spectra after each 
addition of ligand sample. Duration of 2 minutes between each ligand addition is 
allowed for equilibration. The integrated area of each emission spectrum was 
obtained using the Vinci Software and used in the analysis of titration data. All 
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integrated areas were corrected for buffer contribution and changes in volume upon 
addition of ligand. 
 
Data Analysis 
 The steady-state fluorescence titration data were analyzed by non-linear least-
squares analysis using GraphPad Prism 4.0 software package. The stoichiometric 
titrations performed to measure protein activity after purification of variant proteins 
were analyzed using a simple stoichiometric titration model as described in Abbott 
and Beckett (5). The equilibrium titrations of BirA variants with ligands were 
analyzed using a simple one site binding model, to obtain the equilibrium binding 
constant. 
 
I. Stopped-Flow Fluorescence Measurements 
 The initial rates and catalytic efficiency of enzyme-catalyzed synthesis of bio-
5’-AMP from biotin and ATP for BirA wild-type and variant proteins were measured 
by stopped-flow fluorescence using a Kin Tek SF2001 instrument. One syringe 
contained the protein saturated with biotin in standard buffer (10 mM Tris-HCl (pH 
7.50 ± 0.02 at 20.0 ± 0.1 ˚C), 200 mM KCl, 2.5 mM MgCl2), and the other contained 
an ATP sample prepared in the same buffer. The solutions were rapidly mixed in a 
1:1 ratio and the final concentrations of protein and biotin were 1 and 50 µM, with the 
exception of those variant proteins that required higher concentration of biotin to 
ensure saturation. The concentration of ATP was varied from 0.5-3.0 mM. The 
excitation wavelength was set at 295 nm for all measurements and the fluorescence 
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emission was monitored above 340 nm employing a cut off filter. Upon mixing 
sample in both syringes to a final volume of 60 µL, the resulting time-dependent 
decrease in the intrinsic fluorescence was monitored. 
 
Data Analysis 
All data obtained from stopped-flow fluorescence measurements were 
analyzed using the SF 4.0 software package. The initial rates of BirA wild-type and 
variant-catalyzed synthesis of bio-5’-AMP over a range of ATP concentrations were 
analyzed employing a single exponential model: 









exp               (xiv) 
where, F is the fluorescence intensity, A is the amplitude and τ is the relaxation time. 
The values for the catalytic efficiency of bio-5’-AMP synthesis by BirA, kcat/KM, 
were determined from the initial rates of synthesis versus ATP concentration using 
the equation: 











=υ               (xv) 
where, υo is the initial velocity, k2 is the first order rate constant for bio-5’-AMP 
synthesis from biotin and ATP and KM is the Michaelis constant for ATP. 
 
J. Michaelis-Menten Kinetics of BirA-catalyzed biotin transfer to apoBCCP87 
  The kinetics of BirA catalyzed transfer of biotin to BCCP was measured by 
detecting 14C-biotin incorporation into apoBCCP87. All experiments were performed 
by preparing a master mix with 1 mM ATP, 10-25 µM 14C-biotin and apoBCCP87,  
 173 
in standard buffer (10 mM Tris-HCl (pH 7.50 ± 0.02 at 20.0 ± 0.1 ˚C), 200 mM KCl, 
2.5 mM MgCl2), over a range of apoBCCP87 concentrations. The BirA wild-type or 
variant sample was prepared and all samples were incubated at 20 ˚C for 20 minutes. 
The reaction was initiated by addition of BirA to a final concentration of 150 nM at 
t=0. At time points ranging from 30 seconds to 8 minute intervals, a 17 µL aliquot is 
removed from each master mix and quenched with 3.4 µL 1% trifluoroacetic acid and 
5.1 µL of Laemmli low-molecular weight gel sample buffer. Samples were frozen 
immediately in a dry ice/ethanol bath. Samples were heated and loaded onto a 16% 
low molecular weight SDS-polyacrylamide gel (Schagger and von Jagow) to separate 
free 14C-biotin from biotinylated-BCCP87 (holoBCCP87). The gels were fixed and 
dried on Whatmann paper and exposed to a storage phosphor screen for 3 days. Gel 
images were visualized using a Storm phosphorimaging system (Molecular 
Dynamics) and quantified with the Image Quant software. The optical densities of 
bands representative of the 14 C-biotinylated BCCP87 were quantified and plotted 
versus time. Similar quantitation was performed on each gel, representative of a 
specific apoBCCP87 concentration. The initial velocities were obtained from the 
slope of the counts versus time plot. The initial velocities were then plotted versus the 
substrate (apoBCCP87) concentration and fit to the Michaelis-Menten equation:  











                 (xvi) 




VI.  Summary and Future Work 
 A focus of the research in the Beckett Lab is centered on understanding the 
structural basis of multi-functionality in the E. coli Biotin Regulatory System. This 
requires identification of structural determinants important for the distinct functional 
properties of BirA. Here, a combination of biochemical and biophysical approaches 
have been employed to dissect the structural features critical to protein:ligand, 
protein:protein and protein:DNA interactions of BirA. In this work a mutagenesis 
approach combined with detailed thermodynamic characterization of key residues has 
been utilized to probe the role of flexible loops in BirA in the allosteric response and 
in alternative protein:protein interactions that determine the functional switch.  
Results obtained from this research have identified the limited structural determinants 
in BirA required to perform its multiple functions.  
 
 A model for the mechanism of allosteric activation in BirA has been 
formulated and confirmed with extensive thermodynamic, kinetic and structural data 
acquired over the years. In its transcriptional repression function, binding of the 
corepressor, bio-5’-AMP drives dimerization of the repressor and subsequent DNA 
binding. It is therefore, the corepressor-bound form of BirA that is active in DNA 
binding. Detailed investigations indicated that structural and dynamic changes in the 
BirA monomer play a critical role in the allosteric activation process. Further, 
structural and biochemical evidence supported the involvement of a flexible loop in 
the transmission of the allosteric response. This loop is located distal to the 
dimerization interface and folds over the adenine in the adenylate-bound dimer 
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structure. Here, mutations of residues in a hydrophobic cluster in the loop are 
examined to elucidate the ligand-induced allosteric response. Results obtained from 
thermodynamic characterization of mutant proteins indicate that the coupling of 
adenylate ligand binding to dimerization is perturbed. The coupling free energy of 
dimerization is compromised from 1 to 1.5 kcal/mol for each mutant, confirming the 
importance of the hydrophobic cluster to the allosteric response. Additionally, 
formation of the hydrophobic cluster is essential for a disorder-to-order transition of 
the flexible loop. The folding of this low stability region appears to nucleate the 
allosteric response in BirA. 
 
 Recent efforts have focused on investigating the corepressor-linked changes in 
the repressor monomer employing hydrogen-deuterium exchange coupled with mass 
spectrometric analysis (148). In this study, BirA monomer complexed with weak and 
strong activators was probed to assess the degree of protein backbone exchange, as a 
means to determine conformational/dynamic changes in response to ligand binding. 
The results indicated that changes in exchange associated with ligand binding span 
the entire protein. Moreover, the extent of protection of the backbone from exchange 
correlates with the magnitude of the allosteric response. The results of hydrogen-
deuterium exchange have provided an understanding of the change in dynamics 
associated with the allosteric response. The work presented in this thesis indicates the 
importance of the folding of a flexible loop to the functional response in BirA. 
Combining these results has enabled formulation of a model in which, the ligand-
induced folding of the flexible loop appears to nucleate the allosteric response that is 
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then propagated through the protein via changes in dynamics. In order to test this 
model, future work should include subjecting corepressor-bound variants in the 
hydrophobic cluster to hydrogen-deuterium exchange. A comparison of the extent of 
exchange observed for the wild-type and variants should provide information on 
changes associated with nucleation of the allosteric response. Disruption of the cluster 
correlates with a decreased magnitude of the allosteric response. This should affect 
the extent of exchange thereby providing further insight on the transmission of the 
response.   
   
 The structures of apoBirA and ligand-bound BirA dimers have been 
determined to high resolution by x-ray crystallography. To date a structure of the 
protein:DNA complex has not been determined. However, a hypothetical model of 
the holoBirA dimer:operator complex was constructed by Dr. Z.A.Wood. In this 
thesis, predictions based on the model are tested in an effort to elucidate the structural 
mechanism of effector-induced protein:DNA interactions in this system. The 
proposed mechanism involves direct contacts between the DNA backbone and the 
flexible loops involved in intermediate binding and dimerization. Detailed 
thermodynamic analyses of the DNA binding properties of single and multiple site 
mutants in the flexible loops indicated that the structural mechanism does not involve 
direct interaction between the loops and DNA. However, in this work an interesting 
phenomenon was observed that should be investigated in the future. 
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 In the allosteric activation mechanism of BirA, ligand binding is 
thermodynamically linked to DNA binding via two coupled processes. Corepressor 
binding enhances BirA dimerization and subsequent DNA binding. Therefore, the 
energetics associated with assembly of the repression complex (holoBirA 
dimer:bioO) is equivalent to the sum of the energetics of ligand-induced dimerization 
and the energetics of binding bioO. Considering this linkage, defects in ligand-
induced dimerization energetics should correlate with defects in free energies of total 
repression complex assembly. Several corepressor-bound variant proteins, exhibited 
defects in dimerization energetics ranging from 0.8 to 1.5 kcal/mol compared to the 
wild-type repressor. The DNase I footprinting technique was utilized to determine the 
energetics of bioO binding and total repression complex assembly for variants that 
displayed defects in dimerization. Results of these studies indicated no defects in the 
energetics of total repression complex assembly relative to wild-type. In all cases, 
defective dimerization (less favorable free energy) was compensated by a more 
favorable free energy of binding DNA, consequently no difference in total assembly 
energetics was detected. The factors contributing to this compensation in energetics 
are presently unclear. A detailed analysis is imperative to understand this 
phenomenon and could provide valuable information about the linkage between 
thermodynamics and structural features of the protein:DNA interaction.  
    
 Understanding regulation of protein function through alternative 
protein:protein interactions has been an important focus in the E. coli biotin 
regulatory system. Extensive and detailed studies have been performed to understand 
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how the functional switch in BirA is controlled. BirA is its intermediate-bound form, 
holoBirA, switches between alternative protein:protein interactions. It self-associates 
to function as a transcriptional repressor or heterodimerizes with an acceptor protein 
to participate in metabolism. Structural data have revealed that the same BirA surface 
is utilized in both protein:protein interactions, thus rendering them mutually 
exclusive. A large body of data collected in the Beckett Lab, has indicated that the 
two processes are isoenergetic and the functional switch is kinetically controlled. In 
this thesis, an investigation of structural features important for the two protein:protein 
interactions is presented. Single site mutants in the ligand binding loops were 
previously and in this work tested for their homodimerization properties. Results 
indicated a range of defects. While mutation of residues located close to the 
dimerization interface resulted in dramatic defects in dimerization, those located in a 
loop distal to the interface exhibited moderate defects. Employing two methods 
mutant proteins tested for homodimerization properties were assessed for their defects 
in heterodimerization. The results obtained revealed a significant overlap in structural 
determinants important for both protein:protein interactions.  
 
 In the E. coli protein, BirA, limited structural features are important for 
performing multiple functions. The combined results of research presented here have 
indicated the participation of two flexible loops in the multiple functions of the 
protein. Residues in the flexible loop located distal to the dimerization interface are 
integral to transmission of the allosteric response. This is evidenced by the 
compromised coupling between intermediate binding and dimerization of mutant 
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proteins. Moreover, the allosteric response associated with ligand-induced folding of 
this flexible loop affects both homo- and hetero-dimerization processes. In addition, 
the protein has evolved “hotspots” at the dimerization interface that are important for 
specific interaction with itself or with the acceptor protein.  
 
Several lines of evidence have suggested the involvement of the C-terminal 
domain of BirA in its two functions. The adenylate-bound structure of BirA indicates 
that this domain participates in formation of an extended homodimer interface. 
Structural data have also reveal possible interdomain interactions between the C-
terminal domain and the central catalytic domain. Moreover, hydrogen-deuterium 
exchange studies on the BirA monomer indicate the signal associated with ligand 
binding is propagated to C-terminal domain. Future work should include an 
investigation of the role of this domain in hetero- and homodimerization. Such work 
will further elucidate structural determinants important for the multifunctional 
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